Restless leg syndrome

G6_RLS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — G25.8 Hospital discharge: ICD-10 — G25.8 Cause of death: ICD-10 — G25.8 3 out of 7 registries used, show all original rules.	4765
4. Check minimum number of events None	4765
5. Include endpoints None	4765
6. Filter based on genotype QC (FinnGen only)	4765

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF10

NAME	G6_RLS
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	G258
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G258
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G258
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Restless leg syndrome based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	22541	14134	8331
Only index persons	21977	13876	8101
Unadjusted period prevalence (%)
Whole population	0.34	0.40	0.23
Only index persons	0.44	0.51	0.31
Median age at first event (years)
Whole population	64.52	65.47	63.04
Only index persons	64.47	65.40	62.88

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4765	3135	1630
Unadjusted period prevalence (%)	0.95	1.07	0.72
Median age at first event (years)	62.37	61.32	64.39

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4001: Matched controls
40012

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N04BC05

ATC

pramipexole; oral

64.2

323.0

2714

1271

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

+∞

323.0

4001

N03AX12

ATC

gabapentin; oral

4.1

250.1

1161

3588

N03AX16

ATC

pregabalin; oral

3.4

238.7

1541

6222

N06AX11

ATC

mirtazapine; oral

3.1

225.5

1819

8530

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

9.2

199.4

439

526

G47.3

ICD-10 Finland

Sleep apnoea

3.3

196.2

1259

4909

N03AE01

ATC

clonazepam; systemic

5.7

173.3

540

1061

F51.0

ICD-10 Finland

Nonorganic insomnia

3.6

167.1

874

2861

N05AH04

ATC

quetiapine; oral

3.3

159.0

975

3592

M79.6

ICD-10 Finland

Pain in limb

2.4

146.6

1791

9956

N04BC04

ATC

ropinirole; oral

18.3

142.8

226

130

N04

ICPC

Restless legs

29.0

130.0

178

N06AX21

ATC

duloxetine; oral

3.4

123.3

684

2291

N05CF01

ATC

zopiclone; oral

2.3

120.9

1588

8896

N06AB04

ATC

citalopram; systemic

2.4

109.3

1127

5528

N06AX16

ATC

venlafaxine; oral

2.9

107.2

765

3026

N02AX02

ATC

tramadol; systemic, rectal

2.1

105.7

1891

11950

N05BA04

ATC

oxazepam; oral

2.3

101.4

1235

6537

M54.5

ICD-10 Finland

Low back pain

2.1

96.4

1519

8983

R53

ICD-10 Finland

Malaise and fatigue

2.4

94.4

1018

5045

A02BC02

ATC

pantoprazole; systemic

2.0

90.2

2743

20819

N05CF02

ATC

zolpidem; oral

2.4

87.7

914

4429

N02BE01

ATC

paracetamol; systemic, rectal

2.5

86.8

3538

30167

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

84.7

1640

10391

R06.0

ICD-10 Finland

Dyspnoea

2.1

81.9

1160

6451

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.7

81.2

624

2547

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

80.4

1963

13461

M03BX02

ATC

tizanidine; oral

1.9

75.9

2567

19551

A02BC05

ATC

esomeprazole; systemic

1.9

74.7

1748

11697

N06AB10

ATC

escitalopram; oral

2.2

70.8

899

4716

L03

ICPC

Low back symptom/complaint

2.0

69.6

1114

6430

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

69.5

1505

9725

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

96.8

69.1

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

69.1

1107

6391

R03AC02

ATC

salbutamol; inhalant

1.8

68.2

2174

15953

N04BC09

ATC

rotigotine; transdermal

22.0

67.2

N06AX12

ATC

bupropion; oral

3.6

66.3

325

965

M25.5

ICD-10 Finland

Pain in joint

1.9

65.5

1234

7546

M01AH05

ATC

etoricoxib; oral

1.8

65.4

2394

18245

R06.5

ICD-10 Finland

Mouth breathing

2.8

64.1

444

1684

N06AA09

ATC

amitriptyline; systemic

2.6

63.9

536

2275

L17

ICPC

Foot/toe symptom/complaint

1.9

63.2

1132

6775

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

62.4

1171

7124

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

60.6

1256

7898

P06

ICPC

Sleep disturbance

2.6

60.4

492

2051

C07AA05

ATC

propranolol; systemic

2.0

59.5

872

4810

N06AB03

ATC

fluoxetine; oral

2.3

58.8

609

2877

M79.1

ICD-10 Finland

Myalgia

2.3

57.2

617

2971

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.4

56.6

540

2446

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.3

56.0

585

2773

R5140

NOMESCO Finland

Monitoring the use of the aid

2.5

55.3

492

2148

M54.4

ICD-10 Finland

Lumbago with sciatica

2.1

54.5

731

3873

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

53.9

1191

7589

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.6

53.7

424

1732

M03BC51

ATC

orphenadrine, combinations; systemic

1.8

53.2

1175

7478

M03BC01

ATC

orphenadrine (citrate); systemic

1.9

52.7

981

5887

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

4.2

52.4

210

522

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.9

51.3

995

6048

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.1

51.0

657

3413

G25.9

ICD-10 Finland

Extrapyramidal and movement disorder, unspecified

9.3

50.8

108

119

N05CD07

ATC

temazepam; oral

2.2

50.3

567

2775

A02BC01

ATC

omeprazole; systemic

1.8

49.9

1139

7295

M01AB05

ATC

diclofenac; systemic, rectal

1.7

49.1

2619

21326

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.4

48.7

464

2091

G47.9

ICD-10 Finland

Sleep disorder, unspecified

5.1

48.7

161

329

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.2

48.6

277

917

N05BA01

ATC

diazepam; systemic, rectal

2.1

48.6

618

3183

R51.80

ICD-10 Finland

Headache

2.1

48.6

636

3319

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

4.0

48.6

207

544

R01AD09

ATC

mometasone; nasal

1.6

48.5

1777

13051

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

48.3

2723

22452

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

47.3

999

6217

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.9

47.2

314

1152

N06AB06

ATC

sertraline; oral

2.3

46.7

493

2334

R42

ICD-10 Finland

Dizziness and giddiness

1.8

46.7

931

5679

M01AE02

ATC

naproxen; oral, rectal

1.6

46.1

2214

17379

S18

ICPC

Laceration/cut

1.6

45.1

1668

12199

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

45.0

693

3849

L01

ICPC

Neck symptom/complaint

2.1

45.0

606

3189

N06AX26

ATC

vortioxetine; oral

3.0

44.7

273

947

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.6

44.0

359

1485

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

97.2

43.8

M48.0

ICD-10 Finland

Spinal stenosis

2.1

43.8

549

2802

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.0

43.5

618

3320

M70.6

ICD-10 Finland

Trochanteric bursitis

2.1

42.8

573

3006

J01AA02

ATC

doxycycline; systemic

1.7

42.5

3052

26309

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.5

42.3

360

1524

G44.2

ICD-10 Finland

Tension-type headache

2.0

42.1

589

3142

M79.7

ICD-10 Finland

Fibromyalgia

3.6

41.8

200

580

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.2

41.6

490

2433

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

41.5

1694

12620

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

41.4

508

2566

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.1

41.4

241

807

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.4

41.2

371

1620

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

41.2

750

4411

G04BD12

ATC

mirabegron; oral

2.2

40.9

467

2283

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

40.9

1606

11832

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

5.3

39.9

126

245

R52.9

ICD-10 Finland

Pain, unspecified

2.3

39.8

397

1823

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.3

39.8

384

1736

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.6

39.1

301

1204

R35

ICD-10 Finland

Polyuria

2.7

39.0

287

1119

WX110

NOMESCO Finland

Local anesthesy

1.6

39.0

2638

22070

J01DB01

ATC

cefalexin; oral

1.7

39.0

3186

27992

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.4

38.8

369

1655

H02AB06

ATC

prednisolone; systemic

1.6

38.8

1811

13862

R06AE07

ATC

cetirizine; oral

1.6

38.5

1691

12743

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

38.0

1560

11553

N03AX09

ATC

lamotrigine; oral

3.1

37.8

221

742

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

37.2

2089

16632

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

37.2

2411

19845

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.3

37.1

200

636

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

37.1

848

5352

A98

ICPC

Health maint/preventive medicine

2.5

37.0

3839

36146

N06AA06

ATC

trimipramine; systemic

3.9

36.5

154

402

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

36.1

1992

15750

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

36.0

855

5450

P01

ICPC

Feeling anxious/nervous/tense

2.2

35.5

386

1842

R05

ICD-10 Finland

Cough

1.7

35.4

803

5043

P76

ICPC

Depressive disorder

2.6

34.9

275

1115

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

34.7

1460

10809

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.1

34.5

424

2132

110

Kela drug reimbursment

Parkinson's disease and comparable movement disrorders

3.6

34.5

162

463

N06AX03

ATC

mianserin; oral

2.7

34.5

252

977

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.2

34.4

360

1687

R20.2

ICD-10 Finland

Paraesthesia of skin

2.5

34.2

296

1262

H03AA01

ATC

levothyroxine sodium; systemic

1.7

34.1

965

6453

Z01.2

ICD-10 Finland

Dental examination

1.5

34.0

1552

11696

G20

ICD-10 Finland

Parkinson disease

3.4

33.6

168

505

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

33.5

2118

17140

R03DC03

ATC

montelukast; oral

1.8

33.5

638

3786

M01AC06

ATC

meloxicam; systemic, rectal

1.5

33.4

1441

10702

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

33.4

631

3733

N06AX05

ATC

trazodone; oral

3.7

33.3

149

409

SPAT1240

SPAT

Therapeutic discussion

2.1

33.3

415

2100

A04

ICPC

Weakness/tiredness general

1.9

33.1

505

2767

F32

ICD-10 Finland

Depressive episode

2.7

33.1

238

916

Z71.8

ICD-10 Finland

Other specified counselling

1.7

33.0

904

5982

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

4.6

32.8

116

256

M54

ICD-10 Finland

Dorsalgia

2.0

32.6

473

2544

J02AC01

ATC

fluconazole; systemic

1.5

32.6

1556

11811

F32.1

ICD-10 Finland

Moderate depressive episode

2.7

32.4

229

872

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

32.2

1591

12163

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

31.8

1796

14117

N06AX22

ATC

agomelatine; oral

4.3

31.8

120

283

L08

ICPC

Shoulder symptom/complaint

1.7

31.6

753

4782

K02.1

ICD-10 Finland

Caries of dentine

1.5

31.3

2089

16990

R01AD08

ATC

fluticasone; nasal

1.6

31.1

1077

7561

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.0

30.7

189

659

K30

ICD-10 Finland

Functional dyspepsia

2.0

30.7

446

2398

AA1AD

NOMESCO Finland

CT of head and brain

1.6

30.6

908

6121

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

30.5

1071

7536

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

30.5

687

4283

A02BC03

ATC

lansoprazole; oral

1.6

30.4

1129

8050

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.9

30.2

502

2833

P03

ICPC

Feeling depressed

2.1

30.0

344

1677

R25.2

ICD-10 Finland

Cramp and spasm

3.9

29.9

127

334

J45

ICD-10 Finland

Asthma

2.0

29.9

419

2221

J01CA04

ATC

amoxicillin; systemic

1.5

29.8

3070

27247

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

29.5

456

2507

SPAT1263

SPAT

Sampling

1.5

29.4

1599

12398

WX723

NOMESCO Finland

CPAP therapy

3.1

29.2

166

547

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

29.1

818

5425

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.8

29.1

198

737

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

29.0

1631

12725

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

28.9

1510

11594

N05BA12

ATC

alprazolam; oral

1.9

28.8

441

2413

R52.2

ICD-10 Finland

Other chronic pain

3.1

28.7

164

543

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.8

28.7

509

2933

XG466

NOMESCO Finland

Sleep oxymetry

3.1

28.7

161

528

L28

ICPC

Limited function/disability (L)

1.8

28.6

607

3707

R00.2

ICD-10 Finland

Palpitations

2.2

28.5

305

1441

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

28.2

658

4137

SPAT1301

SPAT

No procedures

1.5

28.0

1192

8740

R06AX27

ATC

desloratadine; oral

1.6

28.0

987

6924

A02BA02

ATC

ranitidine; systemic

1.6

27.9

752

4923

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.4

27.9

253

1104

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

27.9

415

2249

A01

ICPC

Pain general/multiple sites

2.1

27.2

328

1634

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

27.0

1174

8635

U02

ICPC

Urinary frequency/urgency

1.8

26.5

521

3102

UJF32

NOMESCO Finland

Coloscopy

1.6

26.5

962

6782

WX780

NOMESCO Finland

Remote monitoring CPAP

2.9

26.4

170

611

R03BA02

ATC

budesonide; inhalant

1.7

26.3

669

4303

L13

ICPC

Hip symptom/complaint

1.7

26.2

626

3955

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

26.0

353

1841

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.8

25.9

512

3056

F34.1

ICD-10 Finland

Dysthymia

2.9

25.8

166

597

XKD00

NOMESCO Finland

Uroflowmetry

1.8

25.7

521

3133

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.1

25.5

307

1524

UKC02

NOMESCO Finland

Cystoscopy

1.7

25.5

564

3480

P01AB01

ATC

metronidazole; oral, rectal

1.5

25.5

1467

11403

C07AB07

ATC

bisoprolol; oral

1.4

25.4

1711

13714

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

25.3

381

2071

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.3

25.2

240

1074

F90.0

ICD-10 Finland

Disturbance of activity and attention

4.0

25.1

103

264

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

25.0

333

1727

J01MA02

ATC

ciprofloxacin; systemic

1.5

24.8

1390

10734

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.9

24.7

410

2304

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.4

24.3

219

953

G43.9

ICD-10 Finland

Migraine, unspecified

2.4

24.3

212

906

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

24.3

715

4774

L02

ICPC

Back symptom/complaint

1.9

24.0

360

1952

N06AB05

ATC

paroxetine; oral

2.2

24.0

255

1200

E0000UV

ATC

1.4

24.0

1442

11269

N30.0

ICD-10 Finland

Acute cystitis

1.7

24.0

537

3325

R01AD12

ATC

fluticasone furoate; nasal

1.5

23.9

1054

7730

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.8

23.9

444

2590

WX290

NOMESCO Finland

Other blockade of nerve

1.4

23.9

1520

12001

N06AA12

ATC

doxepin; systemic

2.3

23.8

228

1020

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.9

23.8

354

1913

A02BC04

ATC

rabeprazole; oral

2.0

23.8

340

1809

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.4

23.8

120

365

KMAK

NOMESCO Finland

1.4

23.8

1883

15481

N03AG01

ATC

valproic acid; systemic, rectal

2.2

23.7

243

1124

F51

ICD-10 Finland

Nonorganic sleep disorders

2.9

23.7

147

516

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.6

23.6

746

5064

L15

ICPC

Knee symptom/complaint

1.6

23.3

782

5388

A06AC51

ATC

ispaghula, combinations; systemic

2.3

23.3

214

940

M01AX05

ATC

glucosamine; oral

1.6

23.2

793

5485

SPAT1216

SPAT

Assessment of functional ability

1.7

23.1

577

3681

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.5

23.0

111

327

SPAT1153

SPAT

Removal of sutures

1.5

22.9

1172

8850

F31.8

ICD-10 Finland

Other bipolar affective disorders

4.0

22.9

241

N87

ICPC

Parkinsonism

4.5

22.7

182

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

22.7

1441

11346

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

22.6

448

2670

R05

ICPC

Cough

1.5

22.6

815

5708

N05AA02

ATC

levomepromazine; systemic

2.6

22.6

176

708

TAB00

NOMESCO Finland

Lumbar puncture

2.5

22.4

185

768

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

22.4

1821

14983

R03BA08

ATC

ciclesonide; inhalant

2.0

22.4

321

1712

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.9

22.3

247

R25.1

ICD-10 Finland

Tremor, unspecified

3.0

22.2

133

455

G25.0

ICD-10 Finland

Essential tremor

3.2

22.1

118

375

G04BD08

ATC

solifenacin; oral

2.0

22.0

275

1391

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.5

21.9

787

5497

R51

ICD-10 Finland

Headache

2.3

21.9

207

921

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.1

21.9

250

1217

R07.3

ICD-10 Finland

Other chest pain

1.9

21.7

359

2014

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

21.7

381

2183

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.6

21.6

165

658

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.3

21.6

198

870

C10AA07

ATC

rosuvastatin; oral

1.5

21.6

875

6283

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

4.6

21.5

165

F45.8

ICD-10 Finland

Other somatoform disorders

2.1

21.4

248

1211

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.8

21.4

247

WZA90

NOMESCO Finland

Other doctors statement

1.5

21.3

818

5795

R60.0

ICD-10 Finland

Localized oedema

1.7

21.3

434

2608

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

21.2

3408

31571

R02

ICPC

Shortness of breath/dyspnoea

1.7

21.2

468

2878

S01GX01

ATC

cromoglicic acid; ophthalmic

1.6

21.2

715

4919

D11

ICPC

Diarrhoea

1.8

21.1

395

2308

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.8

21.1

376

2164

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.5

21.1

935

6836

R03AC03

ATC

terbutaline; inhalant

1.7

21.0

518

3287

SPAT1312

SPAT

General health counselling

1.4

21.0

1164

8898

A06AD11

ATC

lactulose; oral

1.7

20.9

508

3210

D82

ICPC

Teeth/gum disease

1.4

20.9

1201

9243

M01AH01

ATC

celecoxib; oral (coxibs)

1.6

20.8

683

4666

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

20.7

460

2834

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.9

20.7

313

1699

R03BA01

ATC

beclometasone; inhalant

1.6

20.7

527

3375

N05AX12

ATC

aripiprazole; systemic

2.7

20.6

141

528

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.8

20.6

391

2292

G04CA01

ATC

alfuzosin; oral

1.9

20.6

343

1927

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

4.2

20.5

192

M54.1

ICD-10 Finland

Radiculopathy

2.5

20.5

160

646

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

20.4

685

4702

L14

ICPC

Leg/thigh symptom/complaint

2.0

20.4

288

1525

N05AH03

ATC

olanzapine; systemic

2.1

20.4

227

1090

R03BA05

ATC

fluticasone; inhalant

1.6

20.4

649

4397

M02AA07

ATC

piroxicam; topical

1.4

20.3

1356

10711

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

20.3

231

1119

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.9

20.3

304

1646

P20

ICPC

Memory disturbance

1.7

20.2

441

2699

K59.0

ICD-10 Finland

Constipation

2.2

20.2

219

1041

N06BA04

ATC

methylphenidate; oral

3.8

20.2

234

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.5

20.1

954

7063

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.8

20.1

393

2327

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.4

20.0

181

787

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

19.9

504

3219

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.6

19.7

145

567

WX722

NOMESCO Finland

PEEP

2.3

19.6

190

858

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

19.6

773

5501

M01AX17

ATC

nimesulide; oral

1.5

19.5

902

6632

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.4

19.5

278

K59.1

ICD-10 Finland

Functional diarrhoea

2.2

19.5

209

990

J31.0

ICD-10 Finland

Chronic rhinitis

1.9

19.4

290

1570

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.6

19.3

248

M01AH02

ATC

rofecoxib; oral

1.6

19.3

503

3235

A03CA02

ATC

clidinium and psycholeptics; oral

2.0

19.3

248

1263

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.6

19.3

640

4375

D07AC01

ATC

betamethasone; topical

1.4

19.3

1209

9425

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.6

19.3

254

J01FA10

ATC

azithromycin; systemic

1.4

19.2

2080

17767

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.4

19.2

1291

10186

L86

ICPC

Back syndrome with radiating pain

2.1

19.1

223

1095

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

19.1

293

1601

K03.64

ICD-10 Finland

Dental calculus supragingival

1.4

19.1

957

7152

R06AE09

ATC

levocetirizine; oral

1.6

19.1

502

3240

SPAT1260

SPAT

Consultation of another employee

1.5

19.1

661

4565

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

3.4

19.0

278

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.9

19.0

282

1521

S06.0

ICD-10 Finland

Concussion

1.8

19.0

359

2104

A28

ICPC

Limited function/disability NOS

1.6

18.9

524

3424

AA5EN

NOMESCO Finland

Brain reseptor or transprot protein distribution isotope imaging

10.7

18.9

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

18.8

1507

12239

M15

ICD-10 Finland

Polyarthrosis

2.2

18.8

202

957

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.5

18.7

260

G04CA02

ATC

tamsulosin; oral

1.5

18.7

638

4389

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

18.7

1349

10763

J01DA01

ATC

[U] cefalexin; systemic

1.4

18.7

2280

19805

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.3

18.6

180

810

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

18.6

982

7404

A03FA02

ATC

cisapride; oral, rectal

1.9

18.6

300

1666

XA800

NOMESCO Finland

Neuropsychological investigation

2.4

18.4

156

657

J20

ICD-10 Finland

Acute bronchitis

1.8

18.4

354

2087

SPAT1310

SPAT

Counselling related to known health issue

1.4

18.3

1148

8932

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.6

18.3

495

3217

G47.8

ICD-10 Finland

Other sleep disorders

6.0

18.3

P74

ICPC

Anxiety disorder/anxiety state

2.7

18.2

129

494

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

18.0

1200

9430

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.9

17.9

256

1361

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

17.9

620

4279

R74

ICPC

Upper respiratory infection acute

1.4

17.9

941

7081

L60.0

ICD-10 Finland

Ingrowing nail

2.4

17.9

159

689

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

17.8

229

1171

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

17.7

266

1441

R01AD01

ATC

beclometasone; nasal

1.6

17.7

548

3682

SPAT1307

SPAT

Psychosocial counselling and guidance

2.1

17.7

201

977

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

17.5

621

4305

R4110

NOMESCO Finland

Physiotherapy

1.4

17.4

940

7105

IBA03

NOMESCO Finland

Psychotherapy evaluation

6.9

17.4

N05AN01

ATC

lithium; oral

2.9

17.4

110

392

G25

ICD-10 Finland

Other extrapyramidal and movement disorders

17.0

17.4

SPAT1254

SPAT

Administration of medicine

1.6

17.3

510

3382

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

17.2

1108

8639

E66.8

ICD-10 Finland

Other obesity

2.2

17.2

188

895

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

17.2

570

3891

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

17.2

949

7199

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.2

17.1

170

777

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

17.0

532

3580

E61.1

ICD-10 Finland

Iron deficiency

3.8

17.0

187

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

17.0

1619

13456

H02AB07

ATC

prednisone; oral

1.6

17.0

517

3454

R21

ICPC

Throat symptom/complaint

1.5

17.0

641

4501

L12

ICPC

Hand/finger symptom/complaint

1.6

17.0

498

3299

D01

ICPC

Abdominal pain/cramps general

1.7

16.9

367

2240

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

10.7

16.9

R05FB02

ATC

cough suppressants and expectorants

1.4

16.8

1359

11003

SPAT1053

SPAT

Memory test

1.6

16.8

525

3532

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

16.8

1173

9268

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

16.7

562

3845

M03BX01

ATC

baclofen; systemic

3.5

16.7

231

R12

ICD-10 Finland

Heartburn

1.9

16.6

261

1436

WX002

NOMESCO Finland

Sedation and analgesia

1.5

16.6

705

5076

M02AA10

ATC

ketoprofen; topical

1.5

16.6

577

3981

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.8

16.5

106

383

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.6

16.5

123

487

H53.1

ICD-10 Finland

Subjective visual disturbances

2.0

16.5

228

1197

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.2

16.4

165

758

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.8

16.4

107

392

M54.3

ICD-10 Finland

Sciatica

2.0

16.4

218

1131

N17

ICPC

Vertigo/dizziness

1.6

16.3

406

2574

SPAT1243

SPAT

Psychiatric/psychological examination

2.9

16.3

101

358

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

3.7

16.1

191

Z01.7

ICD-10 Finland

Laboratory examination

1.6

16.1

399

2528

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.9

16.0

333

R60.9

ICD-10 Finland

Oedema, unspecified

2.1

16.0

184

898

Z00.0

ICD-10 Finland

General medical examination

1.5

16.0

640

4546

EBA00

NOMESCO Finland

Extraction of tooth

1.4

16.0

1098

8637

D07AB08

ATC

desonide; topical

1.7

16.0

368

2286

S29

ICPC

Skin symptom/complaint other

1.5

15.9

589

4114

R11

ICD-10 Finland

Nausea and vomiting

1.8

15.9

281

1611

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.9

15.8

239

1297

J01FA06

ATC

roxithromycin; oral

1.3

15.7

1439

11840

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.5

15.7

127

525

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.8

15.7

102

373

R25.8

ICD-10 Finland

Other and unspecified abnormal involuntary movements

10.4

15.7

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

8.7

15.7

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.0

15.6

195

986

P29

ICPC

Psychological sympt/compl other

2.0

15.6

190

951

J01EA01

ATC

trimethoprim; systemic

1.4

15.6

902

6887

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

15.5

2047

17758

N39.3

ICD-10 Finland

Stress incontinence

1.8

15.5

288

1679

R13

ICD-10 Finland

Dysphagia

1.9

15.5

238

1301

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.9

15.4

328

L29

ICPC

Musculoskeletal sympt/complt other

1.8

15.4

275

1583

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

15.4

439

2883

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.9

15.3

239

1315

ZXA10

NOMESCO Finland

Bilateral

1.5

15.3

666

4814

J02AC02

ATC

itraconazole; systemic

1.5

15.2

644

4624

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.0

15.2

298

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.4

15.2

712

5218

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.5

15.2

117

471

N03AF01

ATC

carbamazepine; oral, rectal

2.1

15.1

182

907

N76.0

ICD-10 Finland

Acute vaginitis

2.1

15.0

181

901

N06AX17

ATC

milnacipran; oral

3.8

15.0

168

N06AG02

ATC

moclobemide; oral

2.1

15.0

170

827

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

14.8

268

1547

M54.2

ICD-10 Finland

Cervicalgia

1.8

14.8

257

1462

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

14.7

2463

22011

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.4

14.6

213

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

4.0

14.6

147

AA40B

NOMESCO Finland

6.5

14.6

SPAT1058

SPAT

PEF monitoring instruction

1.7

14.5

315

1924

SXC05

NOMESCO Finland

Other oral or dental procedure

1.9

14.5

205

1087

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.5

14.5

116

477

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

14.5

279

1643

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.7

14.5

168

SGA01

NOMESCO Finland

Tooth opening as first aid

1.5

14.4

484

3304

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

14.4

214

1155

C10AA05

ATC

atorvastatin; oral

1.3

14.4

1292

10560

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

2.0

14.4

185

947

A11

ICPC

Chest pain NOS

1.8

14.4

274

1607

M70.7

ICD-10 Finland

Other bursitis of hip

2.6

14.3

108

429

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.5

14.3

483

3302

U07

ICPC

Urine symptom/complaint other

1.9

14.3

207

1107

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

14.3

332

2066

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.1

14.2

155

742

H02AB04

ATC

methylprednisolone; systemic

1.5

14.2

500

3453

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

14.2

1438

11962

N06BA07

ATC

modafinil; oral

9.7

14.2

N04BD01

ATC

selegiline; oral

3.4

14.1

203

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.0

14.1

280

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

14.1

1011

7982

C05AA08

ATC

fluocortolone; rectal, topical

1.5

14.1

494

3407

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.6

14.0

178

N03AX11

ATC

topiramate; oral

2.7

14.0

363

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.7

14.0

328

2047

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.4

14.0

117

494

SBB10

NOMESCO Finland

Teeth copy

1.9

14.0

197

1046

N40

ICD-10 Finland

Hyperplasia of prostate

1.5

14.0

543

3830

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.6

13.9

179

R03AK08

ATC

formoterol and beclometasone; inhalant

2.2

13.9

143

666

N05AX08

ATC

risperidone; systemic

1.8

13.9

256

1485

N01

ICPC

Headache

1.7

13.9

312

1926

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.2

13.8

138

635

M19.8

ICD-10 Finland

Other specified arthrosis

2.3

13.8

130

582

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

13.8

465

3176

H81

ICPC

Excessive ear wax

1.5

13.8

538

3798

G25.3

ICD-10 Finland

Myoclonus

13.6

13.7

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

13.7

823

6301

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

13.6

785

5967

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.8

13.6

257

1503

J34.2

ICD-10 Finland

Deviated nasal septum

2.0

13.5

173

885

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

13.5

690

5132

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

13.5

395

2607

G04BD11

ATC

fesoterodine; oral

2.4

13.5

111

466

SFA00

NOMESCO Finland

Small filling

1.5

13.5

436

2952

N30

ICD-10 Finland

Cystitis

1.7

13.4

264

1563

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.7

13.4

279

1681

ZXA00

NOMESCO Finland

Right side

1.4

13.4

943

7411

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

13.4

603

4379

K08.80

ICD-10 Finland

Toothache NOS

1.8

13.3

253

1484

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

2.0

13.3

175

904

E000001

ATC

1.4

13.3

676

5025

XF402

NOMESCO Finland

ECG with work load test

1.6

13.3

385

2540

R03AC13

ATC

formoterol; inhalant

2.0

13.2

174

897

G04BD07

ATC

tolterodine; oral

1.9

13.2

185

980

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.0

13.2

161

808

SPAT1211

SPAT

Application of soft bandage

1.6

13.2

316

1984

XKC03

NOMESCO Finland

Water cystometry

2.2

13.1

128

584

H01

ICPC

Ear pain/earache

1.6

13.0

354

2296

M54.6

ICD-10 Finland

Pain in thoracic spine

1.8

13.0

230

1320

J01CA08

ATC

pivmecillinam; oral

1.3

12.9

1444

12132

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

12.9

304

1897

R15

ICD-10 Finland

Faecal incontinence

2.3

12.9

115

503

F40.1

ICD-10 Finland

Social phobias

2.9

12.8

258

K04.1

ICD-10 Finland

Necrosis of pulp

1.6

12.8

328

2094

C03CA01

ATC

furosemide; systemic

1.4

12.8

896

7029

L29.9

ICD-10 Finland

Pruritus, unspecified

2.6

12.8

366

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

6.3

12.7

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.8

12.6

296

R06AX22

ATC

ebastine; oral

1.4

12.6

581

4233

K07.60

ICD-10 Finland

Snapping jaw

1.9

12.6

172

903

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

12.6

180

961

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

12.6

433

2969

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

12.6

726

5512

SPAT1234

SPAT

Support of social functional capacity

1.9

12.6

177

937

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

12.5

327

2101

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

2.9

12.5

263

D07AA02

ATC

hydrocortisone; topical

1.5

12.4

431

2959

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

12.4

241

1423

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

12.4

1640

14064

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

12.4

244

1448

N04BC06

ATC

cabergoline; oral (dopamine agonists)

5.8

12.4

-1

NOMESCO Finland

1.3

12.4

1099

8932

L16

ICPC

Ankle symptom/complaint

1.6

12.4

339

2205

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.3

12.3

108

467

SPAT1229

SPAT

Assessment of need for aid

1.7

12.3

280

1730

SPAT1325

SPAT

Vaccination

1.3

12.3

1201

9889

P99

ICPC

Psychological disorders other

2.5

12.3

392

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

12.2

246

1467

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

12.2

882

6948

N04AA02

ATC

biperiden; systemic

2.7

12.2

319

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.5

12.2

467

3277

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.0

12.2

156

801

J01FF01

ATC

clindamycin; systemic

1.3

12.1

896

7078

D07AC13

ATC

mometasone; topical

1.3

12.1

973

7781

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

12.1

217

1249

UJD02

NOMESCO Finland

Gastroscopy

1.9

12.1

164

859

R03BC03

ATC

nedocromil; inhalant

1.7

12.1

250

1503

F51.2

ICD-10 Finland

Nonorganic disorder of the sleep-wake schedule

6.9

12.1

G04BD09

ATC

trospium; oral

2.4

12.0

101

430

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

3.9

12.0

124

X58

ICD-10 Finland

Exposure to other specified factors

1.5

12.0

423

2919

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

12.0

542

3933

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.0

11.9

154

793

F41.00

ICD-10 Finland

Moderate panic disorder

3.2

11.9

198

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

11.9

306

1955

SPAT1043

SPAT

Audiometry

1.6

11.9

353

2339

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.6

11.9

292

1848

M43.1

ICD-10 Finland

Spondylolisthesis

2.0

11.9

142

707

N05AF03

ATC

chlorprothixene; systemic

2.4

11.9

418

N06AB08

ATC

fluvoxamine; oral

2.3

11.8

105

459

A05

ICPC

Feeling ill

1.9

11.8

183

1007

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.2

11.7

116

534

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

11.7

133

650

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.5

11.7

394

2688

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

11.7

830

6509

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.4

11.7

101

434

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.8

11.7

269

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

11.7

318

2066

IGY99

NOMESCO Finland

Other psychiatric treatment contact

3.2

11.7

190

J01MA12

ATC

levofloxacin; systemic

1.4

11.6

591

4382

G43

ICD-10 Finland

Migraine

2.1

11.6

134

660

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

11.6

618

4623

D07AD01

ATC

clobetasol; topical

1.4

11.6

513

3707

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

3.3

11.6

175

E03

ICD-10 Finland

Other hypothyroidism

1.7

11.5

217

1272

G04BD04

ATC

oxybutynin; oral, transdermal

1.8

11.5

190

1068

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

11.5

239

1442

A99

ICPC

Disease/condition unspecnature/site

1.6

11.4

266

1659

D19

ICPC

Teeth/gum symptom/complaint

1.3

11.3

841

6636

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

2.7

11.3

286

R06AX13

ATC

loratadine; oral

1.4

11.3

501

3617

EB1MA

NOMESCO Finland

Cephalometry with X-ray

2.8

11.3

257

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

4.8

11.3

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.6

11.2

322

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.5

11.2

384

2628

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

11.2

528

3860

M77.4

ICD-10 Finland

Metatarsalgia

1.8

11.2

184

1033

R03BB04

ATC

tiotropium bromide; inhalant

1.6

11.2

308

2003

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

11.2

277

1757

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

11.1

194

1109

N02AA05

ATC

oxycodone; systemic

1.5

11.1

459

3270

A01AB09

ATC

miconazole; local oral

1.6

11.1

307

2002

M35.7

ICD-10 Finland

Hypermobility syndrome

3.2

11.0

176

D06

ICPC

Abdominal pain localized other

1.6

11.0

267

1681

H92.0

ICD-10 Finland

Otalgia

1.9

11.0

170

934

S22

ICPC

Nail symptom/complaint

1.8

10.9

192

1101

R39.1

ICD-10 Finland

Other difficulties with micturition

2.4

10.9

399

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.3

10.8

765

5987

B07.9

ICD-10 Finland

Verruca simplex

2.2

10.8

107

494

N05BA06

ATC

lorazepam; systemic, sublingual

1.9

10.8

167

918

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.3

10.8

433

K02

ICD-10 Finland

Dental caries

1.7

10.8

229

1390

N07BB01

ATC

disulfiram; oral

2.0

10.8

134

679

ACC51

NOMESCO Finland

Release of median nerve

1.7

10.8

239

1472

N06AA10

ATC

nortriptyline; systemic

2.5

10.7

339

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.6

10.7

288

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

10.7

518

3807

R33

ICD-10 Finland

Retention of urine

1.7

10.7

216

1292

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.4

10.7

475

3432

A07AA02

ATC

nystatin; oral

1.7

10.6

216

1295

C10AX09

ATC

ezetimibe; oral

1.5

10.6

344

2327

XJH00

NOMESCO Finland

Transanal ultrasonography

1.8

10.6

175

982

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

10.6

188

1081

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.1

10.6

122

602

M76.0

ICD-10 Finland

Gluteal tendinitis

2.6

10.6

292

XA420

NOMESCO Finland

Extensive sleep examination

3.3

10.6

155

H02.3

ICD-10 Finland

Blepharochalasis

1.7

10.6

212

1269

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

3.9

10.5

109

U01

ICPC

Dysuria/painful urination

1.6

10.5

251

1573

ZXA05

NOMESCO Finland

Left side

1.3

10.5

864

6918

L19

ICPC

Muscle symptom/complaint NOS

2.3

10.5

406

F61.0

ICD-10 Finland

Mixed personality disorders

2.8

10.4

224

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

10.4

859

6880

SPAT1051

SPAT

Guidance regarding sleep disorders

2.9

10.4

212

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

10.4

342

2323

A03

ICPC

Fever

1.4

10.3

467

3384

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.8

10.3

111

U05

ICPC

Urination problems other

1.9

10.3

151

813

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.9

10.3

153

830

J05AB01

ATC

aciclovir; systemic

1.3

10.3

699

5434

N02CC04

ATC

rizatriptan; oral

1.8

10.3

185

1071

SPAT1281

SPAT

Other administrative function

1.6

10.3

258

1639

F33

ICD-10 Finland

Recurrent depressive disorder

2.7

10.3

260

WX320

NOMESCO Finland

Spinalanesthesy

1.3

10.3

757

5963

C09CA01

ATC

losartan; oral

1.3

10.2

793

6288

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

10.2

349

2386

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.6

10.2

267

1716

S22.3

ICD-10 Finland

Fracture of rib

1.7

10.2

198

1171

D09

ICPC

Nausea

2.0

10.2

132

682

R06.2

ICD-10 Finland

Wheezing

1.9

10.2

144

768

SPAT1283

SPAT

Restricted health certificate

1.4

10.2

487

3566

G54.0

ICD-10 Finland

Brachial plexus disorders

2.3

10.2

380

XQ800

NOMESCO Finland

Prick test

1.6

10.2

236

1469

R96

ICPC

Asthma

1.5

10.2

306

2037

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

10.1

688

5347

R50.9

ICD-10 Finland

Fever, unspecified

1.4

10.1

433

3102

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.8

10.1

165

924

S02

ICPC

Pruritus

2.1

10.1

116

571

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.0

10.1

125

635

XA421

NOMESCO Finland

Nocturnal polygraphy

5.6

10.1

SDA02

NOMESCO Finland

Parodonthologic therapy

1.3

10.1

1086

9013

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

10.1

432

3100

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.7

10.0

207

1249

R4120

NOMESCO Finland

Occupational therapy

1.7

10.0

200

1194

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

10.0

400

2829

N02CC07

ATC

frovatriptan; oral

2.0

10.0

124

630

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.9

10.0

154

846

K04.0

ICD-10 Finland

Pulpitis

1.6

10.0

278

1817

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

5.8

9.9

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.0

9.9

194

G50.1

ICD-10 Finland

Atypical facial pain

2.7

9.9

237

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.3

9.9

380

S09

ICPC

Infected finger/toe

2.2

9.9

102

478

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.6

9.9

271

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.5

9.9

348

2399

C10AC01

ATC

colestyramine; oral

2.2

9.9

434

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.2

9.8

447

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

9.8

199

1193

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.9

9.8

145

788

C01CA24

ATC

epinephrine; parenteral

1.7

9.8

189

1120

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.6

9.8

268

1742

R01AD05

ATC

budesonide; nasal

1.6

9.7

259

1673

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

9.7

519

3874

P25

ICPC

Phase of life problem adult

2.0

9.7

128

664

G93.3

ICD-10 Finland

Postviral fatigue syndrome

6.5

9.7

OAA65

SPAT

1.6

9.7

249

1594

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

9.7

798

6378

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.9

9.7

132

695

XF404

NOMESCO Finland

Ambulatory ECG

1.5

9.6

303

2037

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.4

9.6

322

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

9.6

507

3775

K02.0

ICD-10 Finland

Caries limited to enamel

1.4

9.6

399

2842

Z71.9

ICD-10 Finland

Counselling, unspecified

1.7

9.6

182

1069

SPAT1377

SPAT

Polysomnography

2.1

9.6

110

543

C10AA04

ATC

fluvastatin; oral

1.6

9.6

278

1834

C10AA01

ATC

simvastatin; oral

1.2

9.5

1423

12267

D03

ICPC

Heartburn

2.1

9.5

107

522

R55

ICD-10 Finland

Syncope and collapse

1.5

9.5

329

2258

H02

ICPC

Hearing complaint

1.4

9.5

395

2817

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

4.0

9.5

DHB50

NOMESCO Finland

Turbinoplasty

2.2

9.5

409

S21

ICPC

Skin texture symptom/complaint

1.4

9.5

400

2860

M15.8

ICD-10 Finland

Other polyarthrosis

2.6

9.5

250

M54.8

ICD-10 Finland

Other dorsalgia

1.9

9.4

134

717

R30.0

ICD-10 Finland

Dysuria

2.0

9.4

117

593

N02CC05

ATC

almotriptan; oral

2.0

9.4

120

618

F41.8

ICD-10 Finland

Other specified anxiety disorders

2.4

9.4

343

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.9

9.4

198

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

9.4

689

5413

C03DA01

ATC

spironolactone; oral

1.5

9.3

324

2223

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.4

9.3

127

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

9.3

248

1600

N07BA03

ATC

varenicline; oral

1.8

9.3

147

816

C09CA06

ATC

candesartan; oral

1.3

9.3

699

5509

R83

ICPC

Respiratory infection other

1.3

9.3

714

5651

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.0

9.3

166

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

9.3

424

3077

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.7

9.2

191

1154

C08CA05

ATC

nifedipine; systemic

1.7

9.2

204

1255

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

9.2

1135

9554

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

9.2

136

736

M75

ICD-10 Finland

Shoulder lesions

1.9

9.2

136

739

N81.6

ICD-10 Finland

Rectocele

1.6

9.2

226

1433

N02AJ13

ATC

tramadol and paracetamol; systemic

2.4

9.1

312

A02BA04

ATC

nizatidine; systemic

1.6

9.1

263

1733

R03AK11

ATC

formoterol and fluticasone; inhalant

2.2

9.1

384

G03FA01

ATC

norethisterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

1.4

9.1

471

3496

M01AB55

ATC

diclofenac, combinations; oral

1.6

9.1

235

1508

G62.8

ICD-10 Finland

Other specified polyneuropathies

4.0

9.1

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.8

9.1

150

844

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.6

9.0

256

SPAT1252

SPAT

Overall medication plan or its review

1.6

9.0

223

1415

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

9.0

852

6933

L84

ICPC

Back syndrome without radiat pain

1.8

9.0

142

788

R32

ICD-10 Finland

Unspecified urinary incontinence

2.1

9.0

103

508

F33.8

ICD-10 Finland

Other recurrent depressive disorders

3.8

9.0

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

9.0

692

5475

R07

ICPC

Sneezing/nasal congestion

1.7

9.0

185

1118

N05BE01

ATC

buspirone; oral

2.1

9.0

473

A01AB04

ATC

amphotericin B; local oral

1.7

8.9

167

979

H13

ICPC

Plugged feeling ear

1.3

8.9

569

4377

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.8

8.9

143

798

J01FA09

ATC

clarithromycin; systemic

1.3

8.8

1033

8632

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

4.9

8.8

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.3

8.8

589

4563

J46

ICD-10 Finland

Status asthmaticus

2.1

8.7

451

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

8.7

234

1516

D12

ICPC

Constipation

1.9

8.7

116

606

C01DA14

ATC

isosorbide mononitrate; oral

1.4

8.7

433

3193

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.3

8.7

334

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.7

8.6

168

997

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.8

8.6

141

792

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

8.6

628

4925

N06AX18

ATC

reboxetine; oral

2.9

8.6

180

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.5

8.6

257

1707

C08CA13

ATC

lercanidipine; oral

1.4

8.6

422

3105

SPAT1262

SPAT

Handing over of treatment supplies

1.3

8.6

569

4399

X72

ICPC

Genital candidiasis female

3.2

8.6

136

E66

ICD-10 Finland

Obesity

1.9

8.6

127

690

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

8.5

299

2060

R1250

NOMESCO Finland

Evaluation of functional capability

2.3

8.5

329

N05

ICPC

Tingling fingers/feet/toes

2.9

8.5

175

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.2

8.5

370

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.3

8.5

810

6593

N06BA12

ATC

lisdexamfetamine; oral

6.4

8.5

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.7

8.5

188

1158

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.5

8.5

248

R30.1

ICD-10 Finland

Vesical tenesmus

2.4

8.4

285

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.0

8.4

103

521

AA400

NOMESCO Finland

Electroconvulsive therapy

3.5

8.4

106

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

8.4

646

5103

B01AB05

ATC

enoxaparin; parenteral

1.3

8.4

998

8349

H29

ICPC

Ear symptom/complaint other

1.5

8.4

325

2285

D02

ICPC

Abdominal pain epigastric

1.7

8.3

179

1095

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

2.4

8.3

270

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.9

8.3

115

611

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

8.3

280

1911

R01AC01

ATC

cromoglicic acid; nasal

1.9

8.3

115

612

S04

ICPC

Lump/swelling localized

1.5

8.3

290

1997

R40.0

ICD-10 Finland

Somnolence

6.2

8.3

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

8.3

347

2477

G23.9

ICD-10 Finland

Degenerative disease of basal ganglia, unspecified

9.4

8.3

A10BJ06

ATC

semaglutide; parenteral

2.0

8.3

100

506

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3420

17287

4.47

307.65

3.6

2.8

103.1

122.3

ug/l

6.92

3119

15995

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1912

10227

2.45

185.44

2.5

2.2

2.8

3.0

mg/l

5.25

1627

8726

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2661

16758

2.33

173.77

2.3

2.0

98.5

95.9

pmol/l

1.80

1367

8477

(3022948) Iron [Moles/volume] in Serum or Plasma

1290

6301

2.44

146.93

2.5

14.4

12.9

umol/l

8.55

1180

5830

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2041

12275

2.16

139.41

2.3

2.1

179.8

209.1

u/l

0.87

1903

11478

(3013707) Erythrocyte sedimentation rate by Westergren method

3869

30079

2.52

135.94

4.8

4.1

11.4

12.6

mm/h

6.42

3594

27817

(3021960) Folate [Moles/volume] in Serum or Plasma

1670

9442

2.18

131.93

1.6

1.5

21.0

20.8

nmol/l

0.24

1438

8041

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1177

5811

2.36

128.57

2.4

2.5

2.4

2.3

g/l

7.82

1079

5366

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3961

31478

2.53

126.42

5.2

4.1

14.8

pmol/l

0.03

3642

28588

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4416

37134

3.58

125.74

6.5

4.9

1.8

2.1

mu/l

2.71

4105

33985

(3015377) Calcium [Moles/volume] in Serum or Plasma

2173

14060

2.00

115.30

2.8

3.4

2.4

mmol/l

0.42

1855

12196

(3019309) Folate [Moles/volume] in Red Blood Cells

1376

7582

2.15

112.85

1.8

1199.9

1171.3

nmol/l

0.48

1037

5729

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2655

18521

1.98

112.22

5.8

5.9

1.2

mmol/l

0.11

2400

16713

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2847

20445

1.98

109.36

6.2

6.7

1.2

mmol/l

0.07

2419

17237

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3868

31127

2.29

107.80

7.5

7.6

76.0

78.3

u/l

3.31

3643

29229

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1066

5415

2.25

106.40

2.6

23.4

22.6

0.81

918

4599

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2449

17143

1.88

96.81

2.4

2.3

78.8

78.1

nmol/l

0.56

2181

15343

(3031040) Bacteria [#/volume] in Urine by Automated count

3407

26763

1.96

91.82

5.8

4.6

557.7

1732.1

e6/l

1.87

351

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1176

6541

2.06

91.09

2.5

3.3

0.8

mmol/l

6.86

1058

6084

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4523

40040

3.55

88.83

18.0

14.4

20.3

23.4

mg/l

9.08

3783

31796

(3019550) Sodium [Moles/volume] in Serum or Plasma

4594

41158

4.24

86.58

20.6

16.5

139.6

139.7

mmol/l

2.12

4520

40130

(3023103) Potassium [Moles/volume] in Serum or Plasma

4599

41276

4.28

85.50

20.8

16.6

4.0

mmol/l

0.70

4521

40176

(3024561) Albumin [Mass/volume] in Serum or Plasma

2436

17565

1.79

82.31

4.1

4.8

36.1

35.5

g/l

8.00

2247

16285

(3013115) Eosinophils [#/volume] in Blood

2783

20876

1.80

82.16

6.3

6.0

0.2

e9/l

0.21

2471

18263

(3006315) Basophils [#/volume] in Blood

2708

20192

1.79

81.15

6.1

5.8

0.0

e9/l

0.01

2358

17355

(3001604) Monocytes [#/volume] in Blood

2694

20098

1.78

80.17

6.1

5.8

0.6

e9/l

3.98

2350

17284

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4237

36701

2.39

79.08

6.8

5.7

39.7

mmol/mol

0.04

3944

33892

(3037467) Urinalysis macro (dipstick) panel - Urine

3457

27859

1.88

78.83

5.2

4.4

—

(3019198) Lymphocytes [#/volume] in Blood

2742

20681

1.77

77.36

6.1

5.9

1.9

e9/l

0.13

2440

18137

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1417

8893

1.84

74.22

1.4

1.3

1.5

1.6

u/ml

0.15

386

2350

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1184

7087

1.89

71.61

1.3

26.2

32.7

iu/ml

1.28

343

2177

(3013826) Glucose [Moles/volume] in Serum or Plasma

3005

23639

1.73

69.36

5.0

4.6

6.5

6.7

mmol/l

6.30

2828

22093

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4367

38823

2.49

68.30

5.6

4.6

5.9

mmol/l

0.11

4028

35330

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1239

7647

1.84

67.38

2.7

3.0

2.4

2.5

mmol/l

3.59

1071

6690

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1365

8683

1.80

67.16

1.7

6283628.0

30455107.4

pmol/l

2.29

1130

7214

(3018418) pH of Serum or Plasma

1767

12224

1.71

64.00

3.7

4.0

7.4

0.26

309

2300

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4260

37724

2.22

62.98

16.1

13.3

80.2

80.3

ml/min/173m2

0.07

3629

31138

(3013650) Neutrophils [#/volume] in Blood by Automated count

2949

23398

1.68

62.72

8.3

9.1

4.1

e9/l

0.36

2613

20379

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3217

26157

1.71

62.02

3.6

3.1

44.1

47.7

u/l

1.36

2995

24261

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2081

15153

1.66

61.28

4.3

3.6

59.0

80.7

ng/l

0.21

1412

10313

(40768797) Stomach Pathology biopsy report

964

5653

1.88

60.86

1.3

1.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2700

21030

1.66

60.80

5.1

6.2

10.5

11.3

umol/l

2.54

2538

19904

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1101

6772

1.81

59.46

1.3

11.1

11.6

u/ml

0.09

412

2621

(3035350) Ketones [Presence] in Urine by Test strip

2556

19702

1.64

59.39

4.3

3.8

0.0

estimate

0.80

482

3637

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1796

12686

1.67

58.82

2.7

2.6

55.9

57.8

u/l

0.68

1637

11673

(3021601) Nitrite [Presence] in Urine by Test strip

2554

19762

1.63

57.77

5.5

5.1

0.0

estimate

0.80

495

3700

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4607

42562

3.49

57.73

12.5

10.5

25.5

u/l

0.05

4479

41000

(3019069) Monocytes/100 leukocytes in Blood

2470

18975

1.63

57.37

6.4

6.3

8.4

8.6

2.43

2290

17719

(3006504) Eosinophils/100 leukocytes in Blood

2458

18862

1.63

57.33

6.2

6.0

2.9

2.8

0.75

2264

17532

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

785

4383

1.95

57.16

1.9

1.7

1.5

0.33

688

3874

(3002030) Lymphocytes/100 leukocytes in Blood

2515

19463

1.62

56.22

6.3

6.1

28.0

27.9

0.31

2311

18081

(40761511) CBC panel - Blood by Automated count

4536

41622

2.87

56.20

16.7

13.5

—

(3009261) Glucose [Presence] in Urine by Test strip

2567

19977

1.62

55.97

4.3

3.8

0.0

estimate

0.37

477

3630

(3018010) Neutrophils/100 leukocytes in Blood

2486

19208

1.62

55.75

6.1

5.9

57.2

57.3

0.13

2294

17908

(42870588) Differential panel, method unspecified - Blood

1892

13697

1.63

55.27

5.7

5.9

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1350

8982

1.70

54.60

1.8

1.2

mg/l

0.08

1001

6853

(3022096) Basophils/100 leukocytes in Blood

2388

18333

1.61

54.51

6.2

6.1

0.7

1.25

2201

17054

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1635

11458

1.65

54.08

3.2

3.0

1276.9

1404.8

ng/l

0.36

1383

9840

(3007164) IgA [Mass/volume] in Serum or Plasma

1198

7767

1.72

53.02

1.5

2.2

2.4

g/l

4.13

688

4674

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4417

40195

2.35

52.81

5.7

4.9

2.7

2.8

mmol/l

2.40

4092

36942

(3036481) Cortisol [Moles/volume] in Serum or Plasma

681

3772

1.94

50.28

2.2

361.1

373.5

nmol/l

0.83

628

3445

(3018095) Leukocytes [#/volume] in Urine

1926

14233

1.59

50.26

4.1

3.7

81.7

103.8

e6/l

0.30

1386

9963

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

503

2520

2.11

49.09

1.3

52.7

48.1

au/ml

0.11

110

(3026493) Urate [Moles/volume] in Serum or Plasma

1497

10472

1.63

48.72

2.6

1729.9

4923.1

umol/l

4.91

1262

9034

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

536

2765

2.06

48.34

2.5

2.4

41.7

23.3

au/ml

1.17

149

(3007461) Platelets [#/volume] in Blood

4694

44331

4.95

47.69

27.6

21.2

252.9

253.0

e9/l

0.05

4636

43206

(3035941) MCH [Entitic mass]

4694

44347

4.92

47.32

27.4

21.1

30.3

0.04

4659

43702

(3024731) MCV [Entitic volume]

4694

44348

4.92

47.29

27.5

21.1

91.2

91.1

0.94

4659

43706

(3026361) Erythrocytes [#/volume] in Blood

4694

44353

4.91

47.18

27.6

21.2

4.5

e12/l

0.64

4618

43098

(3010813) Leukocytes [#/volume] in Blood

4694

44360

4.90

47.02

27.6

21.2

6.8

6.7

e9/l

0.67

4620

43093

(3000963) Hemoglobin [Mass/volume] in Blood

4694

44365

4.90

46.90

27.8

21.3

134.0

134.4

g/l

1.06

4659

43727

(36304419) Bacteria [Presence] in Urine

1529

10866

1.60

46.05

3.3

3.1

—

(3048689) Calprotectin [Mass/mass] in Stool

809

4860

1.80

45.91

2.0

2.2

127.3

137.3

ug/g

0.31

617

3789

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4321

39427

2.03

44.08

5.0

4.4

4.6

4.7

mmol/l

5.01

4017

36437

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4297

39140

2.00

43.94

5.0

4.4

1.5

mmol/l

4.90

3973

35956

(3037522) Nuclear Ab [Titer] in Serum

879

5480

1.74

43.68

1.4

1.3

538.5

551.8

titre

0.06

169

1171

(4010399)

537

2878

1.98

43.30

1.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4178

37764

1.86

42.92

4.5

3.9

1.3

mmol/l

2.84

3818

34417

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2976

24784

1.53

42.32

3.2

2.9

—

(1002224) Polysomnography panel

335

1533

2.27

40.79

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

164

525

3.20

40.54

2.6

2.7

—

(3030467) Casts [#/volume] in Urine by Automated count

1535

11176

1.55

40.42

3.4

3.1

0.3

0.4

e6/l

3.57

1185

8377

(3011397) Hemoglobin [Presence] in Urine by Test strip

1334

9428

1.58

39.97

4.3

3.8

—

(3002582) Erythrocytes [#/volume] in Urine

1628

12112

1.52

38.33

3.5

3.2

44.5

78.9

e6/l

1.83

1272

9220

(3000850) Epithelial cells [#/volume] in Urine

1202

8464

1.56

35.93

2.6

5.0

6.0

e6/l

2.05

1058

7395

(40760892) CBC W Ordered Manual Differential panel - Blood

1238

8789

1.55

35.63

4.3

4.5

—

(3044889) 12 lead EKG panel

3254

28088

1.50

35.27

4.4

3.8

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

223

922

2.49

34.08

2.2

2.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1697

12990

1.48

33.64

3.1

3.2

30.0

35.2

u/l

2.66

1591

12316

(3011288) Drugs identified in Urine by Screen method

204

816

2.57

33.42

3.2

3.0

—

(3000764) Benzodiazepines [Presence] in Urine

258

1178

2.26

31.49

2.2

2.1

—

(3016879) Cocaine [Presence] in Urine

245

1095

2.30

31.46

2.2

2.1

—

(3028300) Cannabinoids [Presence] in Urine

258

1189

2.24

30.79

2.3

2.0

—

(3027008) Opiates [Presence] in Urine

257

1185

2.24

30.64

2.2

2.1

—

(40758558) Short blood count panel - Blood

1377

10309

1.47

29.71

6.4

6.8

—

(3026008) Bacteria identified in Urine by Culture

1648

12785

1.44

29.42

3.4

3.2

—

(3027944) Amphetamines [Presence] in Urine

251

1166

2.22

29.38

2.2

2.0

—

(3009508) Creatinine [Moles/volume] in Urine

1601

12363

1.44

29.27

3.3

3.2

7.4

7.3

mmol/l

0.41

1322

10396

(3020961) Endomysium IgA Ab [Titer] in Serum

350

1850

1.96

29.02

1.2

1.1

353.6

186.4

titre

0.31

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

979

6875

1.53

28.68

3.0

2.7

1.1

1.3

e6/l

0.30

585

3871

(3029937) Albumin [Presence] in Urine by Test strip

1399

10568

1.46

28.60

4.9

4.2

0.0

estimate

0.28

488

3594

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

935

6530

1.54

28.02

2.0

1.8

—

(3019150) Specific gravity of Urine by Refractometry

1173

8604

1.48

27.73

5.0

4.3

1.0

kg/l

0.57

157

1291

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

281

1396

2.08

27.68

1.8

1.7

3.4

3.8

mg/l

0.25

245

998

(3017446) Testosterone [Moles/volume] in Serum or Plasma

406

2290

1.84

27.58

2.7

2.2

12.5

nmol/l

0.05

363

2015

(3000492) Spirometry study

590

3725

1.67

26.95

1.5

1.4

—

(3019225) pH of Specimen

643

4155

1.63

26.80

4.5

4.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

683

4481

1.61

26.76

2.4

2.5

1.7

1.8

0.69

576

3960

(3021589) Normoblasts [#/volume] in Blood

2160

17779

1.39

26.73

10.4

9.5

0.0

e9/l

1.01

1791

14461

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1875

15109

1.40

26.13

4.6

4.0

—

(3044640) Blood type and Crossmatch panel - Blood

1633

12876

1.41

25.74

2.3

2.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

464

2778

1.74

25.74

1.8

2.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

291

1511

1.99

25.36

1.7

1.6

—

(3023368) Bacteria identified in Blood by Culture

1400

10772

1.42

25.25

4.6

4.3

—

(3032080) INR in Blood by Coagulation assay

1981

16198

1.38

24.91

8.4

9.2

1.2

1.3

inr

2.70

566

4652

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

209

973

2.20

24.34

1.2

1.3

562.3

522.2

mg/l

0.17

199

916

(3020630) Protein [Mass/volume] in Serum or Plasma

531

3349

1.66

24.23

2.0

2.6

66.9

66.4

g/l

0.95

488

3055

(3033658) Prothrombin time (PT) actual/Normal

1333

10230

1.42

24.19

4.0

3.9

91.1

90.6

0.31

1284

9969

(3003458) Phosphate [Moles/volume] in Serum or Plasma

759

5214

1.54

24.17

5.0

5.8

1.0

mmol/l

0.08

700

4835

(40768804) Tissue Pathology biopsy report

2036

16786

1.37

24.04

2.2

2.1

—

(36660697) Celiac disease serology panel - Serum

512

3208

1.67

23.95

1.3

1.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

413

2447

1.75

23.71

3.5

3.6

5.2

kpa

0.31

379

2266

(3009343) pH of Capillary blood

408

2415

1.75

23.50

3.5

3.6

7.4

1.40

302

(3013139) Helicobacter pylori Ag [Presence] in Stool

460

2821

1.70

23.31

1.2

—

(3003327) Ova and parasites identified in Stool by Light microscopy

251

1280

2.01

23.01

1.8

1.7

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

187

855

2.24

22.77

1.1

1.3

3.8

mmol/l

0.03

177

799

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2251

18959

1.36

22.72

3.9

4.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

298

1625

1.89

22.45

1.3

1.2

0.8

1.2

u/ml

0.28

155

(3005322) IgE [Units/volume] in Serum or Plasma

411

2469

1.73

22.44

1.3

155.2

194.1

u/ml

0.84

383

2276

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

281

1510

1.91

22.13

3.6

3.9

24.8

24.9

mmol/l

0.17

264

1390

(3044290) Cell count panel - Cerebral spinal fluid

175

788

2.27

22.11

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

149

630

2.41

21.75

2.2

1.9

189.6

198.8

pmol/l

0.40

141

596

(3000494) Fungus identified in Specimen by Culture

691

4757

1.53

21.60

1.5

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

389

2329

1.73

21.48

3.5

3.6

1.5

1.9

mmol/l

1.22

305

1731

(3022313) Gas panel - Capillary blood

311

1754

1.83

21.05

3.4

3.7

—

(3026782) Osmolality of Urine

1050

7899

1.42

20.79

2.6

2.8

528.6

538.7

mosm/kgh2o

0.80

867

6711

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

420

2598

1.68

20.54

3.4

3.3

4.4

pmol/l

0.39

360

2295

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

654

4499

1.53

20.44

1.8

1.7

—

(3013512) EKG study

1466

11692

1.37

20.42

4.3

4.0

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

102

4.64

20.28

1.2

1.4

97.2

130.9

nmol/l

0.97

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

439

2761

1.65

20.12

1.3

1.2

111.0

149.9

iu/ml

1.16

169

1021

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1042

7876

1.41

19.98

4.6

3.7

238.2

506.2

ng/l

1.04

774

6148

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1258

9821

1.38

19.92

2.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

232

1217

1.95

19.63

1.4

290.2

283.1

ug/g

0.21

152

694

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

178

855

2.12

19.19

1.3

1.2

49.5

41.5

u/ml

0.24

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

223

1164

1.96

19.15

1.3

54.5

41.8

u/ml

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

521

3461

1.57

19.00

6.1

6.8

1.3

mmol/l

0.12

506

3342

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

646

4501

1.50

18.91

1.9

1.8

—

(3005719) IgG [Mass/volume] in Serum or Plasma

464

3003

1.60

18.91

2.6

2.7

10.1

10.5

g/l

1.57

430

2732

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

864

6376

1.43

18.81

3.1

2.9

3.5

2.9

e6/l

0.59

470

3395

(3022217) INR in Platelet poor plasma by Coagulation assay

729

5217

1.47

18.67

28.3

25.0

1.3

inr

0.52

751

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

914

6824

1.42

18.63

1.6

1.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

177

860

2.10

18.53

1.3

1.4

8.6

24.3

e6/l

1.38

125

666

(3022145) Colonoscopy Study observation

647

4529

1.50

18.49

1.3

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

177

862

2.09

18.42

1.4

744.6

1200.4

e6/l

0.51

132

702

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

458

2983

1.59

18.16

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

562

3835

1.53

18.12

2.4

31.5

50.8

u/l

0.91

460

3284

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

234

1272

1.88

17.81

1.5

1.8

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

224

1208

1.90

17.47

1.2

—

(3012516) Albumin [Mass/volume] in Urine

1437

11640

1.34

17.47

3.3

3.2

841.4

331.2

mg/l

1.98

879

7230

(3007853) Bacteria identified in Skin by Aerobe culture

664

4723

1.47

17.46

1.8

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

260

1472

1.81

17.38

2.1

2.4

3.0

3.1

g/l

1.23

201

1158

(40761535) Cells panel - Urine sediment

499

3348

1.55

17.36

4.0

3.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

244

1361

1.84

17.12

2.0

2.3

255.0

611.1

ug/l

1.51

225

1270

(3018677) aPTT in Platelet poor plasma by Coagulation assay

827

6150

1.42

17.09

1.9

2.1

29.8

0.11

801

5964

(3014765) Yersinia sp identified in Stool by Organism specific culture

224

1220

1.88

16.95

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

225

1228

1.87

16.92

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

181

920

2.01

16.80

1.3

1.4

10.6

11.1

u/l

0.16

142

750

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

505

3432

1.53

16.54

2.7

2.3

5.2

6.9

ug/l

2.14

427

2993

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

645

4619

1.46

16.31

2.3

2.7

5.6

8.1

umol/l

5.30

513

4005

(3023520) Reticulocytes [#/volume] in Blood

494

3352

1.53

16.29

2.5

70.3

70.0

e9/l

0.06

377

2518

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

335

2076

1.66

16.22

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

364

2306

1.63

16.15

1.6

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

273

2.85

16.11

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

692

5061

1.43

15.58

8.7

6.9

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

200

1081

1.89

15.52

1.3

7.2

7.3

u/ml

0.01

176

(3023323) Follitropin [Units/volume] in Serum or Plasma

292

1769

1.69

15.41

1.4

1.3

28.0

30.6

iu/l

0.62

246

1526

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

266

1571

1.73

15.40

2.0

2.3

7.1

7.4

g/l

1.83

202

1183

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

265

1569

1.73

15.20

2.0

2.3

3.6

3.8

g/l

0.88

197

1131

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

197

1067

1.88

15.19

1.3

6.7

6.5

u/ml

0.02

104

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

265

1570

1.73

15.17

2.0

2.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

626

4523

1.44

15.03

3.5

4.2

234.8

246.2

u/l

1.34

575

4259

(3042936) Bacteria identified in Isolate by Culture

754

5635

1.40

14.97

2.0

—

(3025941) Bacteria identified in Stool by Culture

353

2262

1.61

14.94

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

279

1693

1.69

14.64

1.8

1.9

38.8

39.6

u/l

0.30

246

1508

(3021387) Prolactin [Units/volume] in Serum or Plasma

217

1231

1.80

14.44

1.8

1.6

286.0

303.0

mu/l

0.40

195

1118

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

682

5040

1.41

14.41

5.2

4.5

32.7

32.8

0.08

493

3360

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

297

2.65

14.30

1.2

1.1

39.0

40.2

mg/l

0.07

251

(46235355) HIV 1 and 2 tests - Meaningful Use set

838

6428

1.37

14.14

2.0

1.8

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

247

1464

1.72

14.13

2.1

2.3

9.8

10.2

g/l

1.06

204

1241

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

464

3200

1.50

14.11

3.3

3.7

87.3

89.0

ng/l

0.15

400

2724

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

213

1212

1.79

14.04

1.7

1.6

0.2

g/l

0.64

202

1147

(3017732) Neutrophils [#/volume] in Blood

418

2826

1.53

13.97

2.6

2.9

3.9

4.1

e9/l

1.20

313

2181

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

256

2.76

13.88

1.1

8.4

10.6

nmol/l

0.09

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

368

2424

1.56

13.84

1.8

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

218

1258

1.77

13.70

1.8

1.6

1.2

g/l

0.32

209

1190

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

208

1184

1.79

13.70

2.2

2.3

0.0

g/l

0.44

190

1089

(3000991) Gas panel - Venous blood

467

3245

1.49

13.67

7.7

8.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

296

1867

1.62

13.37

3.9

4.0

24.5

24.2

mmol/l

0.67

258

1683

(3023410) Appearance of Cerebral spinal fluid

386

2.38

13.33

1.6

1.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

286

2.61

13.20

1.1

235.5

266.0

mg/l

0.67

249

(3020682) Albumin/Creatinine [Ratio] in Urine

1464

12271

1.28

12.94

4.2

4.0

9.5

8.8

mg/mmol

0.18

889

7640

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1229

10079

1.30

12.89

5.4

4.9

2.3

2.9

ug/l

1.42

1098

9009

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

269

1673

1.64

12.86

2.0

1.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

212

1238

1.75

12.81

2.2

38.5

37.6

g/l

1.15

181

1064

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1295

10703

1.29

12.77

1.7

1.6

1.4

mmol/l

0.92

1099

8996

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

224

1332

1.72

12.69

1.5

1.6

240.0

302.3

titre

—

(3003396) Base excess in Arterial blood by calculation

610

4516

1.40

12.67

6.3

7.3

1.1

mmol/l

0.03

498

3515

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

185

1047

1.80

12.45

1.3

1.5

22.2

14.3

iu/ml

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

225

1348

1.70

12.40

2.3

2.4

0.4

1.0

g/l

2.89

200

1171

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

160

869

1.87

12.29

1.3

1.2

3.1

3.3

u/ml

0.04

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

192

1106

1.77

12.18

2.3

0.0

g/l

0.50

175

1016

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

190

1092

1.77

12.14

2.3

0.0

g/l

0.00

173

1015

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

359

2.36

12.14

1.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

608

4535

1.39

12.06

6.3

7.3

12.1

12.4

kpa

0.84

581

4311

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

608

4535

1.39

12.06

6.3

7.3

5.1

kpa

0.30

581

4309

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

322

2126

1.55

11.98

2.1

1.8

—

(3014007) Fractional oxyhemoglobin in Arterial blood

363

2461

1.51

11.96

7.8

8.9

94.0

93.9

0.08

363

2452

(3004716) Salmonella sp identified in Stool by Organism specific culture

310

2032

1.56

11.91

1.3

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

204

2.82

11.82

12.4

11.2

0.7

0.6

mmol/l

0.26

184

(3002385) Erythrocyte distribution width [Ratio]

3549

33141

1.28

11.79

21.4

17.5

13.7

0.31

3494

32404

(3016502) Oxygen saturation in Arterial blood

546

4017

1.41

11.73

6.6

7.7

95.8

95.7

0.10

530

3857

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

239

2.66

11.70

1.6

1.5

5.3

7.0

u/l

1.24

202

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

186

1078

1.75

11.57

1.1

2.9

4.8

u/ml

0.68

128

(4034850)

217

1317

1.68

11.42

12.6

9.7

—

(3006653) Thiamine [Moles/volume] in Blood

197

2.81

11.40

1.2

1.3

139.1

135.9

nmol/l

0.22

197

(3023183) Ammonium ion [Moles/volume] in Plasma

148

804

1.87

11.39

3.0

2.8

34.1

35.4

umol/l

0.22

121

681

(3039162) Centromere protein B Ab [Units/volume] in Serum

106

515

2.08

11.24

1.3

56.0

47.4

u/ml

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

110

544

2.05

11.13

6.1

5.1

378.0

360.2

umol/l

0.75

473

(44816559) Phosphatidylethanol [Mass/volume] in Blood

132

700

1.91

10.95

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

410

2.19

10.83

1.5

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

989

8041

1.29

10.81

4.8

4.3

21.1

21.7

0.60

448

3902

(3020891) Body temperature

247

1584

1.59

10.46

5.1

4.4

—

(3024869) Neuronal Ab [Presence] in Serum

4.28

10.29

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

150

849

1.79

10.15

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

150

849

1.79

10.15

1.4

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

501

3733

1.38

9.94

6.9

8.1

121.1

120.9

g/l

0.09

487

3591

(3014576) Chloride [Moles/volume] in Serum or Plasma

637

4954

1.33

9.56

6.8

6.7

104.1

104.3

mmol/l

0.52

626

4849

(3019060) Gas panel - Arterial blood

368

2621

1.44

9.46

4.3

5.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1248

10578

1.24

9.43

3.7

3.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

338

2373

1.46

9.38

2.0

1.8

1.4

g/l

0.15

307

2160

(3052851) Hemolysis interference index of Serum or Plasma

195

1215

1.63

9.33

3.4

3.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

271

1822

1.52

9.32

1.7

1.5

g/l

0.71

231

1565

(3043409) Potassium [Moles/volume] in Arterial blood

192

1192

1.64

9.32

4.1

3.9

mmol/l

0.14

184

1118

(3008898) HLA-B27 [Presence]

211

1342

1.60

9.28

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

324

2261

1.46

9.28

2.5

2.4

—

(4198724)

125

3.06

9.22

2.8

1.8

—

(3020779) Urea [Moles/volume] in Serum or Plasma

470

3514

1.37

9.12

6.8

7.3

9.9

9.8

mmol/l

0.07

449

3348

(4027681)

226

2.45

8.77

1.2

—

(3002032) Base excess in Venous blood by calculation

482

3646

1.36

8.68

4.3

3.7

1.9

2.0

mmol/l

0.17

413

2973

(3042517) Benzodiazepines panel - Urine

5.33

8.67

2.8

1.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

157

946

1.68

8.58

1.3

1.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

3817

36341

1.25

8.57

19.7

15.5

40.0

39.5

4.64

2719

25820

(3021447) Carbon dioxide [Partial pressure] in Venous blood

483

3662

1.35

8.57

4.3

3.7

5.9

5.8

kpa

0.84

467

3558

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

164

2.70

8.55

1.3

2.2

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

723

5811

1.29

8.47

3.5

3.0

0.7

0.8

ug/l

0.49

495

3876

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

439

2.00

8.43

1.6

—

(3049717) Cytology report of Urine Cyto stain

217

1424

1.55

8.37

2.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

489

1.94

8.35

1.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

561

4370

1.32

8.28

1.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

499

3837

1.34

8.06

2.1

2.2

0.2

g/l

2.19

469

3584

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

449

3403

1.35

7.98

3.5

3.8

1.2

mmol/l

1.35

364

2963

(3024891) Influenza virus A+B Ag [Presence] in Specimen

162

1005

1.63

7.94

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

439

1.95

7.74

1.5

1.4

27.8

24.3

iu/ml

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

165

1035

1.62

7.74

1.9

2.0

11.2

11.4

mg/l

0.10

153

948

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

105

582

1.82

7.71

1.3

0.6

nmol/l

0.23

100

556

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

539

1.85

7.70

1.3

1.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

328

2376

1.41

7.70

6.5

7.2

25.0

24.9

mmol/l

0.13

321

2361

(3024354) Oxygen [Partial pressure] in Venous blood

403

3023

1.36

7.66

3.5

3.1

4.6

kpa

0.32

386

2926

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

164

2.57

7.49

2.3

2.0

24.0

69.5

ug/l

0.47

148

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

271

2.19

7.36

1.0

266.7

342.8

ng/l

2.62

175

(3045683) HLA typing for celiac disease panel - Blood or Tissue

227

2.30

7.32

1.1

1.0

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

178

2.49

7.31

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

272

2.18

7.30

1.0

803.8

711.1

ng/l

0.73

171

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

527

1.84

7.29

1.3

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

169

1083

1.58

7.28

1.4

1.3

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

547

4322

1.30

7.26

1.6

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

104

588

1.79

7.18

1.3

0.6

0.3

nmol/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

274

2.17

7.17

1.0

36.6

46.9

ng/l

1.84

174

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

119

700

1.72

7.17

1.2

1.1

1.4

u/ml

0.00

271

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

516

1.84

7.15

1.3

—

nmol/l

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

217

2.32

7.14

1.1

1.0

1.1

u/l

1.07

114

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

518

1.83

7.07

1.9

2.1

13.4

22.6

mg/l

1.90

129

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

195

1300

1.52

7.05

2.4

2.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

533

1.82

7.05

1.3

1.4

—

(3003338) MCHC [Mass/volume]

3546

33716

1.20

6.93

24.4

18.6

331.7

331.9

g/l

0.57

3534

33465

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

265

2.16

6.92

1.2

1.3

—

(40761536) Microorganisms panel - Urine sediment

441

3406

1.32

6.91

4.3

4.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.70

6.90

1.2

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

242

1693

1.45

6.90

2.1

1.9

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

162

1043

1.57

6.86

1.2

1.1

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

284

2050

1.41

6.83

8.0

9.4

24.4

24.3

mmol/l

0.11

268

1915

(3025159) Blasts/100 leukocytes in Blood

401

3061

1.34

6.81

3.8

4.2

0.0

0.4

1.46

743

(3028192) IgG subclass 2 [Mass/volume] in Serum

396

1.93

6.80

1.7

1.4

2.7

2.8

g/l

0.29

276

(3027135) IgG subclass 1 [Mass/volume] in Serum

396

1.93

6.80

1.7

1.4

5.7

6.9

g/l

3.50

274

(3024139) IgG subclass 3 [Mass/volume] in Serum

396

1.93

6.80

1.7

1.4

0.4

g/l

0.51

274

(3017181) Myelocytes/100 leukocytes in Blood

441

3414

1.32

6.80

3.8

4.1

1.0

0.9

0.43

955

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

533

1.80

6.76

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

262

2.15

6.71

1.2

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

421

3244

1.33

6.71

3.8

4.2

0.3

0.2

0.48

879

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

224

1554

1.46

6.68

2.0

1.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

522

4146

1.29

6.66

3.5

3.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

475

3732

1.30

6.58

2.6

2.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

111

2.80

6.57

1.3

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

107

628

1.72

6.53

1.6

0.6

0.8

g/l

1.13

465

(3025468) Yersinia sp identified in Specimen by Organism specific culture

525

1.79

6.50

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

526

1.78

6.46

1.3

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

108

639

1.71

6.41

1.5

1.2

—

(3023511) Choriogonadotropin [Units/volume] in Urine

108

641

1.70

6.34

1.4

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

529

1.77

6.34

1.3

1.4

—

(3037121) Protein [Mass/volume] in Urine

205

1415

1.47

6.30

3.3

3.0

0.3

g/l

0.13

555

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

441

3451

1.31

6.29

2.8

2.9

176.4

196.1

ng/l

0.59

397

3137

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

3.34

6.26

1.1

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

398

3073

1.32

6.26

1.7

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

426

3322

1.31

6.24

2.5

1.9

—

(3002179) Metamyelocytes/100 leukocytes in Blood

402

3110

1.32

6.23

3.6

3.9

0.5

0.6

0.69

688

(4024509)

416

1.86

6.21

1.8

1.6

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

555

1.74

6.20

1.1

0.8

1.9

u/ml

1.25

132

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

113

686

1.66

6.11

1.3

1.4

118.4

115.4

u/ml

0.10

134

(3003888) Timothy IgE Ab [Units/volume] in Serum

104

620

1.69

6.03

1.1

7.2

4.6

u/ml

0.56

311

(3025018) Bordetella pertussis Ab [Titer] in Serum

215

2.20

5.99

1.6

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

218

2.17

5.80

1.5

1.4

71.4

189.7

pmol/l

0.44

(4062490)

397

1.85

5.80

1.8

1.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

143

2.46

5.77

1.3

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

328

2493

1.34

5.76

6.7

6.9

24.9

24.6

mmol/l

0.71

313

2311

(4094501)

159

1065

1.51

5.69

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

480

1.76

5.68

1.1

3.0

3.1

u/ml

0.03

179

(3023430) Cat dander IgE Ab [Units/volume] in Serum

436

1.80

5.68

1.1

8.5

3.7

u/ml

0.60

173

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

310

1.95

5.57

1.1

1.0

288.6

293.5

mg/l

0.20

278

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

432

1.80

5.55

1.1

1.2

58.9

58.3

u/l

0.03

295

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

152

2.38

5.54

1.1

4654.9

451.2

ng/l

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

544

1.70

5.53

1.1

1.6

3.2

u/ml

1.52

243

(3021879) Hepatitis B virus core Ab [Presence] in Serum

358

2773

1.31

5.52

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

654

5451

1.23

5.51

1.6

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.07

5.48

1.3

1.1

—

(3012501) Base excess in Blood by calculation

138

908

1.54

5.39

3.7

4.3

2.5

2.7

mmol/l

0.48

621

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

400

1.81

5.37

1.1

1.2

—

(3013290) Carbon dioxide [Partial pressure] in Blood

138

909

1.53

5.36

3.7

4.3

5.1

5.0

kpa

0.25

132

895

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

239

2.06

5.35

1.1

14.0

9.9

iu/ml

0.16

(3006184) Hemoglobin [Mass/volume] in Capillary blood

135

887

1.54

5.31

2.1

2.2

130.7

128.0

g/l

0.62

631

(3026389) Candida sp identified in Specimen by Organism specific culture

576

1.66

5.22

1.4

—

(3027315) Oxygen [Partial pressure] in Blood

138

915

1.52

5.22

3.7

4.3

8.9

8.5

kpa

1.66

132

900

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

263

1.99

5.16

2.6

2.3

462.6

510.3

e6/l

0.32

221

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

118

760

1.57

5.09

1.1

1.2

—

204.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

105

658

1.61

5.08

1.3

1.4

—

(3000060) B lymphocytes [#/volume] in Blood

2.66

5.07

3.0

1.9

273.9

159.6

e6/l

0.55

(3008401) Mugwort IgE Ab [Units/volume] in Serum

597

1.64

5.05

1.1

1.3

1.2

u/ml

0.04

249

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

427

3426

1.27

5.04

1.4

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

163

1129

1.46

4.99

1.4

1.3

—

(3044927) Protein electrophoresis panel - Urine

410

1.77

4.98

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

118

765

1.56

4.96

1.3

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

398

1.77

4.87

1.1

0.1

0.3

u/ml

1.66

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

104

660

1.59

4.80

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

278

1.92

4.76

1.2

1.3

0.9

1.0

u/ml

0.02

128

(3045414) Leukocytes [Presence] in Urine

250

1882

1.35

4.73

2.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

149

1028

1.46

4.68

1.7

1.8

4.4

4.8

iu/l

0.15

366

(3001019) Free T4 and TSH panel - Serum or Plasma

265

2017

1.33

4.66

1.9

1.7

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

295

1.87

4.63

2.3

2.0

14.0

13.9

0.01

129

(40768443) Skin Pathology biopsy report

238

1787

1.35

4.59

1.2

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

240

1805

1.35

4.58

3.2

2.6

0.7

0.08

231

1728

(3010421) pH of Blood

154

1075

1.45

4.56

3.8

4.1

7.4

0.02

132

894

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

4.41

4.56

1.1

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

385

1.75

4.53

2.6

2.8

—

(3051651) Icteric interference index of Serum or Plasma

248

1.95

4.53

2.8

3.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

632

1.58

4.48

1.2

45.4

43.4

u/l

0.03

537

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

201

2.05

4.47

2.2

2.7

736.4

1382.5

u/ml

1.11

201

(3011412) CD3 cells [#/volume] in Blood

381

1.74

4.40

2.5

2.2

1.1

e9/l

0.04

232

(3051611) Lipemic interference index of Serum or Plasma

427

1.70

4.36

3.0

3.3

—

(3024928) Oxygen saturation in Venous blood

122

823

1.50

4.32

2.7

2.9

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

143

996

1.45

4.31

2.8

3.2

25.3

25.0

mmol/l

0.43

122

869

(1761482) Bacteria [#/volume] in Urine by Culture

1036

0.58

4.30

4.8

4.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

156

1106

1.42

4.27

1.2

—

(3036489) Thrombin time

199

1475

1.36

4.20

1.6

2.1

21.0

21.5

1.08

181

1288

(3040151) Glucose [Moles/volume] in Capillary blood

432

1.68

4.20

3.8

5.5

7.2

7.3

mmol/l

0.13

361

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

171

1238

1.40

4.17

2.4

3.3

1.3

1.6

ratio

0.82

(3034860) Kappa light chains.free [Mass/volume] in Serum

175

1275

1.39

4.11

2.4

3.4

41.1

99.3

mg/l

0.71

148

1034

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

108

719

1.51

4.09

1.1

1.2

333.3

273.2

u/ml

0.64

445

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

4.35

4.08

1.2

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

174

1274

1.38

3.98

2.4

3.4

31.8

58.9

mg/l

1.65

148

1034

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

564

1.57

3.96

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

246

1.88

3.96

1.1

1.2

58.2

87.2

u/l

3.59

217

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

112

757

1.49

3.96

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

165

1201

1.39

3.92

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

550

1.57

3.91

1.3

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

112

2.33

3.91

1.0

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

559

1.57

3.88

1.2

1.4

26.2

29.3

u/l

0.30

456

(3000093) Morphology [Interpretation] in Blood Narrative

358

1.71

3.88

1.2

1.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

123

857

1.45

3.75

3.6

3.0

8.2

8.1

kpa

0.25

114

794

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

302

1.76

3.75

1.1

1.2

72.5

158.0

titre

—

(4146454)

440

1.62

3.70

2.9

2.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

238

1.86

3.68

1.1

1.2

13.4

21.8

u/l

1.33

206

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

143

2.10

3.58

1.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

165

1222

1.36

3.56

1.6

0.3

6.1

iu/ml

0.66

257

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

612

1.51

3.55

1.2

1.1

33.4

16748.4

iu/ml

0.54

140

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

315

1.72

3.54

1.2

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

144

1044

1.39

3.54

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

206

1.90

3.52

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

316

1.72

3.51

1.2

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

179

1.96

3.47

1.1

2.3

5.9

u/ml

—

(3011985) Renin [Units/volume] in Plasma

527

1.55

3.46

1.4

82.1

46.7

mu/l

0.68

464

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.48

3.46

1.5

1.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

303

1.72

3.43

1.3

12.6

12.4

mmol/l

0.05

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

180

1.95

3.42

2.1

2.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

110

765

1.45

3.42

1.1

1.2

—

(1616796) Gas panel - Central venous blood

123

874

1.42

3.40

3.8

3.7

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

319

1.70

3.40

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

319

1.70

3.40

1.2

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

164

1224

1.35

3.38

2.7

2.1

4315.1

4497.6

u/l

0.03

481

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

118

835

1.42

3.35

1.7

1.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

678

1.47

3.34

1.5

1.7

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

315

1.69

3.28

1.2

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

155

1158

1.35

3.20

1.7

2.6

3.5

3.6

g/l

0.22

146

1095

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

192

1.88

3.19

2.2

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

546

1.51

3.19

1.5

1.4

0.3

0.4

nmol/l

1.04

422

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

319

1.67

3.14

1.2

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

373

1.62

3.14

1.7

1.5

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

289

1.70

3.13

2.6

2.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

771

6845

1.15

3.12

1.5

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

147

1095

1.35

3.10

1.2

50.0

120.8

titre

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

180

1.90

3.09

1.4

1.0

3.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

388

3260

1.21

3.07

2.6

66.0

65.3

ml/min/173m2

0.14

163

1301

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

175

1341

1.32

3.05

2.4

3.2

0.3

u/ml

0.22

771

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

667

1.45

3.04

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.59

3.04

2.2

2.0

14.3

16.8

umol/l

0.47

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

347

1.62

2.99

1.6

1.3

1.5

nmol/l

0.53

313

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.24

2.96

1.0

1.1

1259.9

278.3

pmol/l

0.44

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

264

1.71

2.95

1.4

1.5

6.0

6.4

u/l

0.04

125

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

617

1.45

2.87

1.2

1.1

—

(3007463) Buprenorphine [Presence] in Urine

5.39

2.87

3.9

2.8

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

511

1.50

2.86

1.1

1.5

g/l

0.36

457

(3028717) Thiamine [Mass/volume] in Blood

2.93

2.85

1.0

1.3

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

375

1.58

2.85

2.1

2.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

128

947

1.36

2.85

1.5

—

(3021788) Differential panel - Synovial fluid

101

720

1.41

2.81

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.92

2.77

1.0

—

(3014271) Vancomycin [Susceptibility]

217

1.76

2.75

3.2

2.9

—

(44813793)

271

1.67

2.71

1.0

1.1

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

189

1.80

2.70

1.6

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

189

1.80

2.70

1.6

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

147

1125

1.32

2.64

1.8

2.5

190.3

191.9

0.07

140

1071

(3023419) Bacteria identified in Sputum by Culture

513

1.47

2.62

2.8

2.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.55

2.61

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

489

1.48

2.61

1.3

272.7

298.2

pmol/l

0.22

379

(3002256) Pathology report gross observation

605

5350

1.15

2.60

1.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

267

1.65

2.59

1.9

1.4

51.4

70.0

umol/l

—

(3038515) Glucose [Moles/volume] in Venous blood

837

0.65

2.58

3.7

3.2

6.7

7.6

mmol/l

2.09

816

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.90

2.58

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

2.19

2.57

1.8

2.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

125

939

1.34

2.56

1.4

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

394

1.53

2.55

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

199

1593

1.26

2.53

2.1

2.0

1.0

2.2

ug/l

2.68

174

1406

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.60

2.53

1.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

245

2011

1.23

2.50

2.7

0.3

e6/l

0.11

238

1954

(3008037) Lactate [Moles/volume] in Venous blood

890

0.67

2.49

3.5

3.1

1.5

1.6

mmol/l

0.08

867

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

504

1.46

2.45

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

127

963

1.33

2.45

1.7

11014.0

12929.3

e6/l

0.24

676

(3022621) pH of Urine by Test strip

320

2707

1.20

2.41

3.5

3.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

650

1.39

2.38

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

541

1.43

2.37

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

113

848

1.34

2.35

3.0

2.4

16.7

16.1

0.76

421

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.61

2.35

1.2

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

213

1.70

2.35

1.1

21.5

3.0

u/ml

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

338

1.54

2.34

1.6

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

338

1.54

2.34

1.6

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

338

1.54

2.34

1.6

1.5

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

444

1.47

2.32

2.4

1.9

17.0

25.1

ug/l

1.54

437

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

133

1.88

2.30

3.2

2.7

27.9

29.7

umol/l

0.32

(3003181) Sodium [Moles/volume] in Urine

732

1.36

2.28

1.2

1.4

68.8

62.2

mmol/l

0.82

589

(3004616) Nuclear Ab [Presence] in Serum

521

1.43

2.27

1.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

4.62

2.27

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.02

2.25

1.1

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

156

1.80

2.25

1.2

1.1

—

(3015183) Erythrocyte sedimentation rate

194

1.71

2.22

1.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

264

1.60

2.20

2.3

1021.2

709.3

e6/l

1.19

112

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

467

1.44

2.18

1.6

1.5

48.4

59.4

1.15

289

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

218

1.66

2.18

1.2

1.1

—

(3042631) Mycobacterium sp identified in Specimen

534

1.41

2.18

2.8

3.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.37

2.12

1.7

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

555

1.39

2.10

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

106

804

1.33

2.09

2.7

3.7

57.2

57.5

0.08

106

804

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.20

2.09

1.1

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

213

1.65

2.09

1.0

1.1

8.3

1.2

u/ml

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

213

1.65

2.09

1.0

1.1

18.4

26.2

u/l

0.65

160

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

213

1.65

2.09

1.0

1.1

70.3

82.6

u/l

0.78

165

(3045424) Erythrocytes [Presence] in Urine

710

1.34

2.07

1.5

1.6

—

(3021901) Oxygen saturation in Capillary blood

702

1.35

2.06

3.2

2.8

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.50

2.05

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

3.50

2.05

1.0

1.1

—

(3003129) Base excess in Capillary blood by calculation

103

1.95

2.05

1.1

1.8

0.1

1.1

mmol/l

0.72

(3006270) Folate [Moles/volume] in Blood

350

1.49

2.04

1.2

328.6

363.5

nmol/l

0.64

304

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

287

1.54

2.00

1.7

1.6

—

(40760888) Immunoglobulin light chains.free panel - Serum

123

961

1.29

1.98

2.1

3.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

296

1.53

1.97

1.4

1.5

1.4

1.2

promille

0.27

227

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

386

1.46

1.96

4.0

3.8

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

529

1.39

1.95

4.8

6.8

12.0

11.9

mg/l

0.13

492

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

479

1.40

1.93

1.7

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

250

1.56

1.92

1.5

1.3

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.31

1.87

1.9

2.0

—

(3017509) Phencyclidine [Presence] in Urine

2.86

1.86

3.9

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.03

1.85

1.3

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.39

1.85

1.0

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

167

1.68

1.83

1.4

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

354

0.56

1.83

1.0

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

100

771

1.30

1.80

3.8

5.2

2462.9

615.7

iu/ml

0.48

109

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.06

1.80

1.7

1.6

151.0

103.8

ng/l

0.31

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

168

1.67

1.80

1.3

2.5

120.9

144.9

umol/l

0.19

(3035320) C reactive protein [Mass/volume] in Body fluid

295

1.50

1.79

4.6

2.4

—

(21494815) CD4 cells/100 lymphocytes in Specimen

312

1.48

1.77

2.1

2.2

51.9

44.9

—

(3002523) Influenza virus A Ag [Presence] in Specimen

556

1.35

1.77

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

280

2413

1.17

1.77

3.4

3.1

131.3

128.4

g/l

1.44

274

2350

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.03

1.74

2.8

2.6

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

173

1430

1.22

1.74

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

118

935

1.27

1.74

1.6

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

141

1143

1.24

1.71

2.0

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

603

1.33

1.71

1.5

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

258

1.52

1.70

1.5

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

449

1.39

1.70

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

122

974

1.26

1.69

2.3

2.2

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

1.95

1.69

1.9

2.2

8.8

7.7

mmol/l

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

111

1.81

1.68

1.1

2.2

1.4

u/ml

0.18

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.18

1.67

1.2

140.8

78.1

ng/l

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

599

1.32

1.63

1.3

1.2

5.8

4.8

u/ml

0.26

254

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

687

1.30

1.62

1.5

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

428

1.38

1.62

3.1

3.8

—

(4015189)

1.84

1.61

2.6

2.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

149

1227

1.22

1.58

1.7

2.3

91.9

92.0

0.03

141

1148

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

106

1.80

1.58

1.2

1.1

—

(3012565) Volume of 24 hour Urine

199

1.56

1.9

2.4

1921.0

1920.2

0.00

179

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.28

1.53

2.6

1.7

39.1

41.0

umol/l

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.34

1.52

1.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

357

1.40

1.52

1.5

1.4

34.0

30.9

0.22

214

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

425

1.37

1.51

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

391

1.39

1.51

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

408

1.38

1.51

1.4

2.1

8.3

7.9

umol/l

0.06

289

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.16

1.50

1.4

—

(21494755) Public health laboratory ask at order entry panel

298

3382

0.87

1.49

1.3

—

(3048879) Bone marrow aspiration report

116

1.73

1.48

1.2

1.7

—

(3020491) Glucose [Moles/volume] in Blood

292

1.44

1.48

2.6

2.3

6.7

6.8

mmol/l

0.10

192

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.84

1.45

1.1

1.3

—

(3030313) Adrenal Ab [Titer] in Serum

2.50

1.45

1.0

1.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

691

1.28

1.44

1.7

1.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.88

1.44

1.2

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

3.13

1.44

1.2

1.0

0.4

0.7

u/ml

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.73

1.43

7.7

4.7

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

312

1.41

1.40

1.1

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

330

1.40

1.38

1.1

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

222

1.49

1.38

1.7

1.4

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.94

1.36

1.0

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

220

1907

1.16

1.35

4.2

3.2

25.4

mmol/l

0.16

215

1848

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

779

1.25

1.34

2.3

2.0

0.7

0.8

nmol/l

0.62

648

(21494890) Protein electrophoresis panel - 24 hour Urine

418

1.34

1.33

1.4

2.0

—

(44806118)

444

1.33

1.2

1.4

—

(44790048)

444

1.33

1.2

1.4

—

(44790049)

444

1.33

1.2

1.4

—

(44790047)

444

1.33

1.2

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

367

1.37

1.32

1.2

1.3

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

2.50

1.30

1.0

1.1

9.5

8.3

mmol/l

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

756

1.25

1.29

2.7

2.9

—

(3004451) EKG impression Narrative

201

1.50

1.29

1.3

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

318

1.39

1.28

1.7

1.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

174

0.52

1.28

1.8

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

544

1.29

1.27

1.5

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

441

1.32

1.24

1.6

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

103

843

1.23

1.22

1.7

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

112

925

1.22

2.2

2.4

107.1

94.4

ug/min

0.15

553

(3000285) Sodium [Moles/volume] in Blood

1.97

1.22

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.72

1.21

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.72

1.21

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.72

1.21

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.72

1.21

1.0

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

501

0.72

1.20

2.6

2.4

3.9

4.0

mmol/l

2.26

495

(3035285) Chloride [Moles/volume] in Venous blood

501

0.72

1.20

2.6

2.4

105.7

105.3

mmol/l

0.24

495

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

523

1.29

1.19

1.5

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

793

1.23

1.18

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

243

2150

1.14

1.16

9.2

10.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

102

1.67

1.16

1.2

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

240

1.42

1.15

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

615

1.26

1.15

1.3

1.2

1.9

3.9

u/ml

1.61

201

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.50

1.15

1.0

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

361

1.33

1.13

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.34

1.12

1.3

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

159

1.51

1.11

1.6

2.0

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

119

1.60

1.11

1.1

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

193

1.45

1.08

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.95

1.08

1.0

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

144

1.53

1.08

1.1

1.2

0.3

g/l

0.80

114

(3033705) Calcium.ionized [Moles/volume] in Venous blood

490

0.73

1.07

2.6

2.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

227

1.41

1.07

1.8

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

202

1.44

1.07

1.4

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

202

1.44

1.07

1.4

1.6

—

(37021550) Renin [Units/volume] in Plasma --upright

1.67

1.03

1.2

1.3

132.8

57.6

mu/l

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.27

1.03

1.0

—

(3051593) INR in Capillary blood by Coagulation assay

187

1.45

1.03

8.4

12.7

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.00

1.00

2.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

197

1.42

0.99

1.9

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

197

1.42

0.99

1.9

1.6

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

197

1.42

0.99

1.9

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

197

1.42

0.99

1.9

1.6

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

189

1.43

0.98

5.1

4.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.84

0.98

1.0

1.1

1.6

1.7

umol/24h

—

(3022475) Manganese [Moles/volume] in Blood

2.18

0.98

1.0

1.3

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

1.67

0.97

1.1

1.3

0.3

109.0

mg/l

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

152

1322

1.15

0.97

1.5

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.80

0.96

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

116

1.55

0.96

2.3

2.6

—

(44806420)

117

0.51

0.94

2.2

2.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

373

1.29

0.93

1.5

1.4

117893.0

82932.2

e6/l

0.14

248

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.22

0.93

1.8

1.5

2.0

4.6

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

2.22

0.93

1.8

1.5

3.1

2.2

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.22

0.93

1.8

1.5

0.6

1.3

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.22

0.93

1.8

1.5

4.8

1.1

mg/l

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

391

1.28

0.93

4.1

4.7

131.1

54.2

u/ml

0.35

106

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

226

1.37

0.92

1.8

1.6

—

(3003694) ABO and Rh group [Type] in Blood

1126

10786

1.06

0.91

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

118

1.53

0.90

1.2

1.1

—

(4212803)

1.91

0.88

1.0

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.65

0.88

1.2

1.3

—

104.5

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.79

0.87

1.4

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.79

0.87

4.7

5.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.86

0.87

1.0

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

144

1.46

0.87

1.6

1.8

40.7

59.2

ug/l

2.07

139

(3000012) Reticulocyte production index

203

1.38

0.87

1.3

1.5

—

(1761868) Lipid panel - Serum or Plasma

1419

13702

1.05

0.85

2.9

2.8

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

603

0.79

0.85

1.3

1.4

—

(3008295) Osmolality of Serum or Plasma

442

1.25

0.84

1.5

286.6

278.1

mosm/kgh2o

1.75

339

(3002619) Bacteria identified in Specimen by Culture

1.63

0.84

1.5

1.2

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

1.63

0.84

1.1

1.3

106.5

105.9

0.02

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.78

0.84

1.1

1.2

—

(3036603) Volume of Urine

265

1.32

0.84

1.3

1.4

1421.0

1939.8

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.76

0.83

1.8

1.6

—

(3005033) Fetal Nuchal fold Thickness US

600

0.80

0.82

1.3

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

622

0.80

0.82

1.3

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

682

1.19

0.80

1.4

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

236

0.68

0.80

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

176

0.62

0.79

1.3

1.6

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.00

0.77

0.0

1.2

—

26.7

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

0.00

0.77

0.0

1.2

—

29.4

—

(3037756) Immunofixation for Serum or Plasma

835

1.17

0.75

1.4

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

132

1.44

0.75

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

185

0.65

0.75

1.4

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

124

1.45

0.75

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

351

1.26

0.74

1.0

—

(3016038) Potassium [Moles/volume] in Urine

271

1.29

0.74

1.1

1.2

30.1

34.7

mmol/l

0.83

237

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.80

0.72

1.1

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.80

0.72

3.3

2.6

0.3

0.7

u/field

—

(4268621)

416

1.23

0.71

2.4

2.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.75

0.71

1.0

1.8

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

309

1.26

0.70

1.3

1.5

10.5

12.5

umol/l

1.69

291

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

160

1.38

0.70

1.8

2.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.53

0.68

1.8

1.3

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

1.85

0.68

1.4

1.2

—

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.85

0.68

1.4

2.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.63

0.66

1.3

1.1

—

(3044941) Cell count panel - Synovial fluid

650

1.17

0.66

1.5

1.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.49

0.66

1.0

1.1

0.7

umol/24h

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.79

0.66

2.8

9.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

162

1.36

0.66

3.0

2.6

—

(3020650) Glucose [Presence] in Urine

111

1.44

0.65

1.4

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

215

1.30

0.65

1.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.72

0.64

1.2

1.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

216

1.30

0.63

1.5

1.3

1.4

1.2

nmol/l

0.25

168

(3017704) Immunofixation for Urine

225

1.29

0.63

1.1

1.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

270

1.26

0.62

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

164

1.34

0.62

1.1

1813.1

1495.6

miu/ml

0.61

164

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.63

0.62

1.8

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.67

0.61

1.2

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

1.67

0.61

1.0

0.0

1.1

u/ml

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

130

1.39

0.61

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

113

1.42

0.61

1.1

1.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

156

1.35

0.61

2.4

2.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

307

3284

0.93

0.59

1.8

1.7

—

(3025130) Human papilloma virus identified in Specimen

546

1.17

0.59

1.9

1.7

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

227

1.28

0.59

1.3

5.4

5.9

mmol/l

1.92

216

(3047181) Lactate [Moles/volume] in Blood

141

1271

1.11

0.59

5.2

6.7

1.4

1.3

mmol/l

0.32

127

1110

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

183

1.31

0.59

1.2

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

399

1.21

0.59

2.8

3.3

62.5

57.6

0.70

258

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

114

1.40

0.58

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

114

1.40

0.58

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

735

0.86

0.58

1.3

1.4

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.56

0.58

1.7

1.6

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.58

0.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.51

0.58

1.0

—

(3024471) HLA-A [Type]

112

0.62

0.58

1.1

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

734

0.86

0.57

1.3

1.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.72

0.57

1.0

1.2

8.7

19.3

u/l

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

733

0.86

0.57

1.3

1.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.67

0.56

1.2

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

732

0.86

0.56

1.3

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.45

0.55

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

126

0.63

0.54

1.1

1.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.49

0.53

1.3

1.2

2.7

1.7

mmol/l

—

(3000330) Specific gravity of Urine by Test strip

194

2097

0.92

0.51

3.2

3.5

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.46

0.50

1.2

1.5

—

(3044009) aPTT.lupus sensitive (LA screen)

1.46

0.50

1.5

1.2

—

(3028433) Virus identified in Specimen by Culture

127

1.34

0.49

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

216

1.25

0.49

1.6

1.5

7.7

7.9

mmol/l

0.10

133

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.56

0.49

1.0

1.1

—

(3024932) HLA-DR beta [Type]

108

0.65

0.48

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

253

2372

1.07

0.48

3.0

3.6

36.2

57.0

u/ml

1.14

237

2285

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.49

0.47

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.49

0.47

1.1

1.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

152

1651

0.92

0.47

4.8

5.6

0.9

0.02

141

1541

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

665

0.87

0.46

1.4

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

120

1.33

0.46

1.3

1.1

—

(3018133) Calcium [Moles/volume] in Urine

1.43

0.46

2.7

2.0

3.5

3.0

mmol/l

—

(3011648) Oxygen content in Venous blood

319

1.19

0.45

1.9

2.2

11.4

11.2

0.12

319

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

255

1.22

0.45

1.8

1.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

201

1.25

0.44

2.1

166.4

148.8

ug/min

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

137

1489

0.92

0.44

3.1

3.4

176.7

3490.8

u/ml

1.06

118

1259

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

154

1663

0.92

0.43

4.9

5.5

1.7

1.6

0.17

143

1548

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.43

0.42

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.43

0.42

12.6

9.1

5.7

mmol/l

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.43

0.42

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.40

0.42

1.4

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

176

1.25

0.41

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.38

0.41

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.38

0.41

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.38

0.41

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

105

1.33

0.41

4.6

1.6

—

(3013762) Body weight Measured

0.00

0.40

0.0

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

204

1.23

0.40

1.9

1.7

2.7

u/field

0.01

145

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

123

1.30

0.40

1.1

1.2

80.8

89.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

804

0.89

0.40

1.3

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

250

1.20

0.40

1.1

—

(3019977) pH of Arterial blood

205

1.22

0.39

1.8

3.0

7.4

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.3

—

1.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

251

1.20

0.39

1.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

836

1.10

0.39

3.6

3.1

0.9

0.8

nmol/l

0.23

644

(4281824)

474

0.86

0.38

1.3

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

207

2199

0.94

0.38

1.5

1.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

133

1.28

0.38

1.8

2.0

—

(40768446) Kidney Pathology biopsy report

151

1.26

0.38

1.7

1.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

112

1029

1.09

0.38

3.7

3.2

1.6

1.5

mg/l

0.24

100

944

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.32

0.37

1.2

1.0

—

(3001729) Color of Synovial fluid

1.35

0.37

1.2

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

487

1.13

0.36

1.1

—

(3047189) Immunofixation for 24 hour Urine

191

0.78

0.36

1.8

1.5

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

253

1.19

0.36

1.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

226

1.20

0.35

3.0

2.7

43.3

40.4

0.30

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

451

4345

1.04

0.35

3.4

4.0

7.4

25.0

ug/l

3.38

361

3499

(3009871) Measles virus Ab [Titer] in Serum

123

0.73

0.35

1.7

—

(40765096) Chromosome analysis panel by Banding

124

0.73

0.35

1.2

1.1

—

(3019174) dRVVT (LA screen)

1.40

0.35

1.5

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.40

0.35

1.3

1.2

—

640.5

—

(40768806) Pleura Pathology biopsy report

405

0.86

0.34

1.5

1.6

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.33

0.33

1.7

2.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.30

0.33

1.3

1.1

—

(3006462) Nitrate [Presence] in Urine

182

1.21

0.33

3.6

3.8

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

128

1.25

0.31

2.0

49298.0

22503.9

e6/l

—

(3016750) Collection duration of Urine

220

1.18

0.31

1.8

2.1

473.7

491.2

min

0.33

166

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.35

0.31

1.1

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

102

1.28

0.30

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.23

0.29

1.0

1.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

112

1.25

0.28

2.1

2.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

112

1.25

0.28

2.1

2.8

—

(4035726)

380

3672

1.04

0.28

1.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

1.28

0.28

1.2

144.3

362.3

ug/l

—

(40762365) Oxygen content in Arterial blood by calculation

1.25

0.27

3.1

2.6

14.2

14.9

ml/dl

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

131

1.22

0.27

1.1

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.21

0.26

1.1

1.7

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.28

0.26

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

136

1285

1.06

0.26

1.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

110

1036

1.06

0.24

1.2

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

124

1.21

0.24

1.1

85.6

88.8

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.32

0.23

1.0

1.1

—

3.8

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.25

0.22

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.25

0.22

1.4

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

907

0.94

0.22

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

133

1399

0.95

0.22

1.3

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

200

1.15

0.22

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

219

1.14

0.22

1.5

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

273

0.88

0.21

1.7

1.8

—

(21494434) Karyotype in Bone marrow

353

1.11

0.21

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.21

0.0

3.9

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.21

0.0

1.0

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.21

0.0

1.1

—

5.8

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.21

0.0

2.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

441

1.09

0.20

1.2

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

278

1.12

0.20

1.6

1.7

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

240

1.13

0.20

1.0

1.1

1.0

ratio

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.22

0.20

1.7

2.2

—

(44806071)

1.22

0.20

1.0

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

292

0.89

0.20

2.1

1.5

1.0

g/l

0.23

292

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

250

1.12

0.19

1.1

1.2

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

1.18

0.19

1.0

1.4

83.5

76.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

308

1.10

0.19

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

308

1.10

0.19

1.1

1.2

—

(3034426) Prothrombin time (PT)

138

1.16

0.17

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

382

0.92

0.17

1.1

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.71

0.16

2.6

3.2

—

(3035880) pH of Pleural fluid

215

0.88

0.16

1.2

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

402

0.92

0.16

2.2

2.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

474

0.93

0.16

1.4

5586.2

1907.5

e6/l

0.68

342

(3004809) Band form neutrophils/100 leukocytes in Blood

651

1.06

0.16

2.5

3.4

1.2

1.4

0.29

508

(40768800) Prostate Pathology biopsy report

628

0.94

0.16

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

583

1.06

0.16

1.9

1.6

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.76

0.15

2.3

8.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.80

0.14

1.0

—

(3045142) Bone marrow Pathology biopsy report

450

1.07

0.14

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

509

1.06

0.14

1.4

1.3

6.9

7.3

mmol/l

0.45

379

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

161

1.12

0.13

2.2

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

161

1.12

0.13

2.2

1.7

—

(3024263) Appearance of Synovial fluid

219

1.10

0.12

2.0

1.7

—

(4133840)

1.18

0.12

1.4

1.2

—

(4306422)

600

1.05

0.12

1.2

—

(3022689) Creatine [Moles/volume] in Urine

116

0.86

0.12

1.1

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

163

1.10

0.10

2.2

1.7

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

309

1.07

0.10

1.6

1.5

21.6

20.0

u/ml

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.14

0.10

1.0

1.5

—

(4211845)

203

1.08

0.09

3.6

3.7

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.06

0.09

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

381

0.94

0.09

1.2

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

145

0.90

0.09

1.7

1.8

—

(3017569) Oxygen content in Arterial blood

184

1.09

0.09

1.5

2.4

—

(3000034) Microalbumin [Mass/volume] in Urine

360

1.06

0.09

2.8

3.1

18.6

34.6

mg/l

1.13

261

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

126

1.11

0.09

1.2

1.1

—

(3033799) Differential panel - Peritoneal fluid

126

1.11

0.09

3.3

1.9

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

156

1.09

0.08

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

0.83

0.07

1.5

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.81

0.07

1.0

1.6

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.05

0.07

1.1

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.04

0.07

1.0

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

265

0.94

0.07

6.5

6.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

393

1.04

0.07

1.2

1.5

2.9

3.7

ug/l

0.45

339

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

0.88

0.06

1.5

1.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.87

0.06

2.9

7.5

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

0.85

0.06

1.3

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

100

0.90

0.06

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

188

1.06

0.05

2.4

3.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

425

0.96

0.05

1.3

1.4

44993.8

72400.1

e6/l

0.46

241

(3004775) Volume in Urine collected for unspecified duration

303

0.96

0.05

2.0

2.2

576.8

626.4

0.31

203

(3043410) Blood group antigens tested for on Red Blood Cells

110

0.91

0.05

1.0

1.8

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

863

1.02

0.04

5.4

3.5

22.9

25.8

mg/l

0.39

530

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

494

0.97

0.04

1.2

1.5

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

115

1132

1.02

0.04

1.3

267.1

221.2

miu/ml

0.66

535

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

318

1.04

0.04

1.9

2.1

2.6

1.8

u/field

0.33

125

(40768441) Liver Pathology biopsy report

309

1.04

0.03

1.5

1.4

—

(3013727) Leukocytes other/100 leukocytes in Blood

129

0.93

0.03

1.8

3.6

60.0

54.4

0.37

124

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

250

0.96

0.03

1.2

—

(3039000) Anion gap in Blood

917

1.01

0.03

6.4

7.7

10.5

11.2

mmol/l

1.41

815

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

102

1.08

0.03

1.3

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

609

1.02

0.02

1.1

—

(40768795) Lymph node Pathology biopsy report

410

1.02

0.02

1.2

—

(3018572) Chloride [Moles/volume] in Blood

918

1.01

0.02

6.4

7.7

104.9

105.1

mmol/l

0.25

816

(3042733) HLA Ab [Presence] in Serum

113

1.06

0.01

5.0

5.3

—

(3012441) Differential panel - Pleural fluid

393

1.02

0.01

1.3

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

106

0.94

0.01

1.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

124

1.05

0.00

1.5

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

136

0.96

0.00

1.2

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

594

1.01

0.00

1.6

1.7

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

142

0.99

0.00

1.0

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

115

0.96

0.00

1.8

3.2

5.3

7.6

mg/l

1.26

(3023487) Leukocytes [#/volume] in Peritoneal fluid

145

0.97

0.00

2.3

2.2

274.4

866.7

e6/l

—

103

(40768793) Breast Pathology biopsy report

103

1035

1.00

0.00

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

116

1.03

0.00

2.3

1.5

8.5

8.7

ug/l

0.12

116

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

103

0.97

0.00

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

196

1.02

0.00

1.4

2.2

—

(3044007) Cell count panel - Peritoneal fluid

117

1.03

0.00

3.4

2.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

1.7

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.86

0.00

2.6

7.9

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.3

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

9.0

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

44.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.7

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.1

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.0

1.0

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(40758292) HTLV I+II Ab panel - Serum

0.91

0.00

1.2

1.3

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1205.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

99.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

37.2

—

(3052592) Norovirus Ag [Presence] in Stool

1.00

0.00

1.5

1.4

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_RLS and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_RLS	1.061 [0.92, 1.23]	0.425
Birth year	0.993 [0.98, 1.0]	0.087

During the follow-up period (1.1.1998 — 31.12.2019), 1342 out of 10279 females with G6_RLS died.

Males

Parameter	HR [95% CI]	p-value
G6_RLS	1.246 [1.07, 1.45]	0.004
Birth year	0.988 [0.98, 1.0]	0.009

During the follow-up period (1.1.1998 — 31.12.2019), 1193 out of 6145 males with G6_RLS died.

Mortality risk

Mortality risk for people of age

years, who have G6_RLS.

N-year risk	Females	Males
1	0.061%	0.23%
5	0.57%	1.436%
10	1.463%	3.607%
15	2.728%	6.773%
20	4.931%	11.498%

Relationships between endpoints

↥

Index endpoint: G6_RLS – Restless leg syndrome

GWS hits: 8

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Restless leg syndrome

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints